# EDGAR Filing Document

**Accession Number:** 0000880266
**File Stem:** 0000880266-25-000061
**Filing Date:** 2025-10
**Character Count:** 215773
**Document Hash:** d6dc5efa2006b89b61c858de73f9099f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000880266-25-000061.hdr.sgml**: 20251031

**ACCESSION NUMBER**: 0000880266-25-000061

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 107

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251031

**DATE AS OF CHANGE**: 20251031

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AGCO CORP /DE
- **CENTRAL INDEX KEY:** 0000880266
- **STANDARD INDUSTRIAL CLASSIFICATION:** FARM MACHINERY & EQUIPMENT [3523]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 581960019
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-12930
- **FILM NUMBER:** 251439110

**BUSINESS ADDRESS:**
- **STREET 1:** 4205 RIVER GREEN PKWAY
- **CITY:** DULUTH
- **STATE:** GA
- **ZIP:** 30096
- **BUSINESS PHONE:** 7708139200

**MAIL ADDRESS:**
- **STREET 1:** 4205 RIVER GREEN PARKWAY
- **CITY:** DULUTH
- **STATE:** GA
- **ZIP:** 30096

?xml version='1.0' encoding='ASCII'? agco-20250930

    

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 10-Q** 

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended September 30, 2025** 

**OR**

---

| | |
|:---|:---|
| ☐ | **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** |
| | **For the transition period from _________ to _________** |

---

**Commission File Number: 001-12930** 

**AGCO CORPORATION**

(Exact name of Registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **Delaware** | **58-1960019** |
| (State or other jurisdiction of incorporation or organization) | (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
| **4205 River Green Parkway** | **4205 River Green Parkway** | |
| **Duluth,** | **Georgia** | **30096** |
| (Address of principal executive offices) | (Address of principal executive offices) | (Zip Code) |

---

**(770) 813-9200**

(Registrant's telephone number, including area code)

---

| | | |
|:---|:---|:---|
| **Securities registered pursuant to Section 12(b) of the Act** | **Securities registered pursuant to Section 12(b) of the Act** | **Securities registered pursuant to Section 12(b) of the Act** |
| **Title of Class** | **Trading Symbol** | **Name of exchange on which registered** |
| Common stock | AGCO | New York Stock Exchange |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

☒ Yes □ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

☒ Yes □ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

☒ Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes **☒** No

As of October 27, 2025, there were 74,623,566 shares of the registrant's common stock, par value of $0.01 per share, outstanding.

------

**AGCO CORPORATION**

**INDEX**

---

| | | |
|:---|:---|:---|
| | | Page<br>Numbers |
| **<u>[PART I. FINANCIAL INFORMATION:](#icbbdaa10cdc945cb841aacb61b001220_10)</u>** | **<u>[PART I. FINANCIAL INFORMATION:](#icbbdaa10cdc945cb841aacb61b001220_10)</u>** | **<u>[PART I. FINANCIAL INFORMATION:](#icbbdaa10cdc945cb841aacb61b001220_10)</u>** |
| Item 1. | <u>[Financial Statements (unaudited)](#icbbdaa10cdc945cb841aacb61b001220_13)</u> |  |
|  | <u>[Condensed Consolidated Balance Sheets as of](#icbbdaa10cdc945cb841aacb61b001220_16)[September](#icbbdaa10cdc945cb841aacb61b001220_16)[30, 2025 and December 31, 2024](#icbbdaa10cdc945cb841aacb61b001220_16)</u> | <u>[3](#icbbdaa10cdc945cb841aacb61b001220_16)</u> |
|  | <u>[Condensed Consolidated Statements of Operations for the Three Months Ended](#icbbdaa10cdc945cb841aacb61b001220_19)[September](#icbbdaa10cdc945cb841aacb61b001220_19)[30, 2025 and 2024](#icbbdaa10cdc945cb841aacb61b001220_19)</u> | <u>[4](#icbbdaa10cdc945cb841aacb61b001220_19)</u> |
|  | <u>[Condensed Consolidated Statements of Operations for the](#icbbdaa10cdc945cb841aacb61b001220_22)[Nine](#icbbdaa10cdc945cb841aacb61b001220_22)[Months Ended](#icbbdaa10cdc945cb841aacb61b001220_22)[September](#icbbdaa10cdc945cb841aacb61b001220_22)[30, 2025 and 2024](#icbbdaa10cdc945cb841aacb61b001220_22)</u> | <u>[5](#icbbdaa10cdc945cb841aacb61b001220_22)</u> |
|  | <u>[Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and](#icbbdaa10cdc945cb841aacb61b001220_25)[Nine](#icbbdaa10cdc945cb841aacb61b001220_25)[Months Ended](#icbbdaa10cdc945cb841aacb61b001220_25)[September](#icbbdaa10cdc945cb841aacb61b001220_25)[30, 2025 and 2024](#icbbdaa10cdc945cb841aacb61b001220_25)</u> | <u>[6](#icbbdaa10cdc945cb841aacb61b001220_25)</u> |
|  | <u>[Condensed Consolidated Statements of Cash Flows for the](#icbbdaa10cdc945cb841aacb61b001220_28)[Nine](#icbbdaa10cdc945cb841aacb61b001220_28)[Months Ended](#icbbdaa10cdc945cb841aacb61b001220_28)[September](#icbbdaa10cdc945cb841aacb61b001220_28)[30, 2025 and 2024](#icbbdaa10cdc945cb841aacb61b001220_28)</u> | <u>[7](#icbbdaa10cdc945cb841aacb61b001220_28)</u> |
|  | <u>[Notes to Condensed Consolidated Financial Statements](#icbbdaa10cdc945cb841aacb61b001220_31)</u> | <u>[8](#icbbdaa10cdc945cb841aacb61b001220_31)</u> |
| Item 2. | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#icbbdaa10cdc945cb841aacb61b001220_97)</u> | <u>[40](#icbbdaa10cdc945cb841aacb61b001220_97)</u> |
| Item 3. | <u>[Quantitative and Qualitative Disclosures about Market Risk](#icbbdaa10cdc945cb841aacb61b001220_124)</u> | <u>[55](#icbbdaa10cdc945cb841aacb61b001220_124)</u> |
| Item 4. | <u>[Controls and Procedures](#icbbdaa10cdc945cb841aacb61b001220_127)</u> | <u>[55](#icbbdaa10cdc945cb841aacb61b001220_127)</u> |
| **<u>[PART II. OTHER INFORMATION:](#icbbdaa10cdc945cb841aacb61b001220_130)</u>** | **<u>[PART II. OTHER INFORMATION:](#icbbdaa10cdc945cb841aacb61b001220_130)</u>** |  |
| Item 1. | <u>[Legal Proceedings](#icbbdaa10cdc945cb841aacb61b001220_133)</u> | <u>[56](#icbbdaa10cdc945cb841aacb61b001220_133)</u> |
| Item 1A. | <u>[Risk Factors](#icbbdaa10cdc945cb841aacb61b001220_136)</u> | <u>[56](#icbbdaa10cdc945cb841aacb61b001220_136)</u> |
| Item 2. | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#icbbdaa10cdc945cb841aacb61b001220_139)</u> | <u>[56](#icbbdaa10cdc945cb841aacb61b001220_139)</u> |
| Item 5. | <u>[Other Information](#icbbdaa10cdc945cb841aacb61b001220_142)</u> | <u>[56](#icbbdaa10cdc945cb841aacb61b001220_139)</u> |
| Item 6. | <u>[Exhibits](#icbbdaa10cdc945cb841aacb61b001220_145)</u> | <u>[57](#icbbdaa10cdc945cb841aacb61b001220_145)</u> |
| **<u>[SIGNATURES](#icbbdaa10cdc945cb841aacb61b001220_148)</u>** | **<u>[SIGNATURES](#icbbdaa10cdc945cb841aacb61b001220_148)</u>** | <u>[58](#icbbdaa10cdc945cb841aacb61b001220_148)</u> |

---

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**PART I.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;FINANCIAL INFORMATION**

**ITEM 1.&nbsp;&nbsp;&nbsp;&nbsp;FINANCIAL STATEMENTS**

**AGCO CORPORATION**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

**(unaudited and in millions, except share amounts)**

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| **ASSETS** | **ASSETS** | **ASSETS** |
| Current Assets: |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $884.1 | $612.7 |
| &nbsp;&nbsp;&nbsp;Accounts and notes receivable, net | 1220.9 | 1267.4 |
| &nbsp;&nbsp;&nbsp;Inventories, net | 3081.1 | 2731.3 |
| &nbsp;&nbsp;&nbsp;Other current assets | 535.6 | 526.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 5721.7 | 5138.0 |
| Property, plant and equipment, net | 1977.4 | 1818.6 |
| Right-of-use lease assets | 169.0 | 168.9 |
| Investments in affiliates | 597.3 | 519.6 |
| Deferred tax assets | 898.3 | 561.0 |
| Other assets | 512.2 | 435.2 |
| Intangible assets, net | 689.8 | 728.9 |
| Goodwill | 1901.2 | 1820.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $12466.9 | $11190.6 |
| **LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY** | **LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY** | **LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS' EQUITY** |
| Current Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Borrowings due within one year | $109.2 | $415.2 |
| &nbsp;&nbsp;&nbsp;Accounts payable | 986.7 | 813.0 |
| &nbsp;&nbsp;&nbsp;Accrued expenses | 2410.2 | 2469.6 |
| &nbsp;&nbsp;&nbsp;Other current liabilities | 122.0 | 128.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 3628.1 | 3826.0 |
| Long-term debt, less current portion and debt issuance costs | 2734.4 | 2233.3 |
| Operating lease liabilities | 123.4 | 127.5 |
| Pension and postretirement health care benefits | 163.1 | 155.6 |
| Deferred tax liabilities | 143.7 | 125.0 |
| Other noncurrent liabilities | 882.1 | 680.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 7674.8 | 7147.7 |
| Commitments and contingencies (Note 17) |  |  |
| Redeemable noncontrolling interests | 301.3 | 300.1 |
| Stockholders' Equity: |  |  |
| &nbsp;&nbsp;Preferred stock; $0.01 par value, 1,000,000 shares authorized, no shares issued or outstanding in 2025 and 2024 |  |  |
| &nbsp;&nbsp;Common stock; $0.01 par value, 150,000,000 shares authorized, 74,623,113 and 74,420,952 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively | 0.7 | 0.7 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 16.0 |  |
| &nbsp;&nbsp;&nbsp;Retained earnings | 6206.7 | 5645.0 |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (1732.6) | (1902.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 4490.8 | 3742.8 |
| Total liabilities, redeemable noncontrolling interests and stockholders' equity | $12466.9 | $11190.6 |

---

See accompanying notes to condensed consolidated financial statements.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**AGCO CORPORATION**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(unaudited and in millions, except per share data)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| | **2025** | **2024** |
| Net sales | $2476.3 | $2599.3 |
| Cost of goods sold | 1829.8 | 1996.2 |
| Gross profit | 646.5 | 603.1 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Selling, general and administrative expenses | 340.8 | 344.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Engineering expenses | 123.0 | 121.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 23.0 | 8.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment charges | (0.6) | 0.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and business optimization expenses | 8.7 | 10.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on sale of business |  | 3.2 |
| Income from operations | 151.6 | 114.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | 15.5 | 33.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expense (income), net | (208.4) | 52.3 |
| Income before income taxes and equity in net earnings of affiliates | 344.5 | 28.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax provision | 48.8 | 11.9 |
| Income before equity in net earnings of affiliates | 295.7 | 16.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity in net earnings of affiliates | 7.0 | 12.2 |
| Net income | 302.7 | 28.9 |
| Net loss attributable to noncontrolling interests | 3.0 | 1.1 |
| Net income attributable to AGCO Corporation | $305.7 | $30.0 |
| Net income per common share attributable to AGCO Corporation: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $4.10 | $0.40 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $4.09 | $0.40 |
| Cash dividends declared and paid per common share | $0.29 | $0.29 |
| Weighted average number of common and common equivalent shares outstanding: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 74.6 | 74.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 74.7 | 74.7 |

---

See accompanying notes to condensed consolidated financial statements.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**AGCO CORPORATION**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**(unaudited and in millions, except per share data)**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** |
| Net sales | $7161.8 | $8774.6 |
| Cost of goods sold | 5336.1 | 6564.2 |
| Gross profit | 1825.7 | 2210.4 |
| Operating expenses: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Selling, general and administrative expenses | 993.0 | 1074.5 |
| &nbsp;&nbsp;&nbsp;&nbsp;Engineering expenses | 356.8 | 390.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 54.0 | 54.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;Impairment charges | 7.3 | 5.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and business optimization expenses | 37.3 | 41.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss on sale of business | 12.3 | 497.8 |
| Income from operations | 365.0 | 146.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net | 51.8 | 65.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other expense (income), net | (127.2) | 168.4 |
| Income (loss) before income taxes and equity in net earnings of affiliates | 440.4 | (87.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax provision (benefit) | (154.7) | 122.6 |
| Income (loss) before equity in net earnings of affiliates | 595.1 | (210.0) |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity in net earnings of affiliates | 30.7 | 38.0 |
| Net income (loss) | 625.8 | (172.0) |
| Net loss attributable to noncontrolling interests | 5.2 | 2.9 |
| Net income (loss) attributable to AGCO Corporation | $631.0 | $(169.1) |
| Net income (loss) per common share attributable to AGCO Corporation: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $8.46 | $(2.27) |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $8.45 | $(2.27) |
| Cash dividends declared and paid per common share | $0.87 | $3.37 |
| Weighted average number of common and common equivalent shares outstanding: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 74.6 | 74.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 74.7 | 74.7 |

---

See accompanying notes to condensed consolidated financial statements.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**AGCO CORPORATION**

**CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)**

**(unaudited and in millions)**

---

| | | |
|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| | **2025** | **2024** |
| Net income | $302.7 | $28.9 |
| Other comprehensive income (loss): |  |  |
| &nbsp;&nbsp;Foreign currency translation adjustments | 34.0 | 81.0 |
| &nbsp;&nbsp;Defined pension and postretirement benefit plans, net of tax | 2.1 | 2.0 |
| &nbsp;&nbsp;Deferred gains and losses on derivatives, net of tax | (3.9) | 1.6 |
| Other comprehensive income | 32.2 | 84.6 |
| Comprehensive income | 334.9 | 113.5 |
| Comprehensive loss attributable to noncontrolling interests | 3.0 |  |
| Comprehensive income attributable to AGCO Corporation | $337.9 | $113.5 |

---

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** |
| Net income (loss) | $625.8 | $(172.0) |
| Other comprehensive income (loss): |  |  |
| &nbsp;&nbsp;Foreign currency translation adjustments | 174.4 | (107.1) |
| &nbsp;&nbsp;Defined pension and postretirement benefit plans, net of tax | 6.0 | 5.6 |
| &nbsp;&nbsp;Deferred gains and losses on derivatives, net of tax | (3.7) | 6.5 |
| Other comprehensive income (loss) | 176.7 | (95.0) |
| Comprehensive income (loss) | 802.5 | (267.0) |
| Comprehensive loss (income) attributable to noncontrolling interests | (1.2) | 2.8 |
| Comprehensive income (loss) attributable to AGCO Corporation | $801.3 | $(264.2) |

---

See accompanying notes to condensed consolidated financial statements.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**AGCO CORPORATION**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**(unaudited and in millions)**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** |
| Cash flows from operating activities: |  |  |
| &nbsp;&nbsp;Net income (loss) | $625.8 | $(172.0) |
| &nbsp;&nbsp;Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 187.3 | 189.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 54.0 | 54.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock compensation expense | 25.0 | 21.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Impairment charges | 7.3 | 5.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Loss on sale of business | 12.3 | 497.8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of investment in affiliate | (251.9) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity in net earnings of affiliates, net of cash received | (30.0) | (37.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income tax benefit | (348.8) | (30.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 23.4 | 24.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts and notes receivable, net | 81.1 | (102.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | (113.4) | (221.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current and noncurrent assets | (29.2) | (79.7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 98.6 | (77.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | (241.4) | (286.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other current and noncurrent liabilities | 124.4 | 105.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total adjustments | (401.3) | 64.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) operating activities | 224.5 | (108.0) |
| Cash flows from investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;Purchases of property, plant and equipment | (159.3) | (279.3) |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of property, plant and equipment | 1.7 | 1.8 |
| &nbsp;&nbsp;Purchase of businesses, net of cash acquired |  | (1902.2) |
| &nbsp;&nbsp;Proceeds from sale of business | (12.3) |  |
| &nbsp;&nbsp;Sale of (investments in) unconsolidated affiliates, net | 258.8 | (1.6) |
| &nbsp;&nbsp;&nbsp;Other | (7.7) | (0.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) investing activities | 81.2 | (2181.5) |
| Cash flows from financing activities: |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from indebtedness | 481.6 | 2624.6 |
| &nbsp;&nbsp;&nbsp;Repayments of indebtedness | (458.0) | (2.3) |
| &nbsp;&nbsp;&nbsp;Payment of dividends to stockholders | (64.9) | (251.5) |
| &nbsp;&nbsp;&nbsp;Payment of minimum tax withholdings on stock compensation | (11.4) | (11.9) |
| &nbsp;&nbsp;&nbsp;Payment of debt issuance costs |  | (15.7) |
| &nbsp;&nbsp;Investments by noncontrolling interests, net |  | 8.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) financing activities | (52.7) | 2351.3 |
| Effects of exchange rate changes on cash, cash equivalents and restricted cash | 18.4 | (14.7) |
| Increase in cash, cash equivalents and restricted cash | 271.4 | 47.1 |
| Cash, cash equivalents and restricted cash, beginning of period | 612.7 | 595.5 |
| Cash, cash equivalents and restricted cash, end of period<sup>(1)</sup> | $884.1 | $642.6 |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Includes $20.0 million of cash and cash equivalents classified as held for sale as of September 30, 2024.

See accompanying notes to condensed consolidated financial statements.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**AGCO CORPORATION**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**(unaudited)**

**1.&nbsp;&nbsp;&nbsp;&nbsp;BASIS OF PRESENTATION**

&nbsp;&nbsp;&nbsp;&nbsp;The condensed consolidated financial statements of AGCO Corporation and its subsidiaries (the "Company" or "AGCO") included herein have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") for interim financial information and the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which are of a normal recurring nature, necessary to present fairly the Company's financial position, results of operations, comprehensive income (loss) and cash flows at the dates and for the periods presented. These condensed consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024. Results for interim periods are not necessarily indicative of the results for the year. Certain prior-period amounts have been reclassified in the accompanying condensed consolidated financial statements and notes thereto in order to conform to the current period presentation.

&nbsp;&nbsp;&nbsp;&nbsp;The Company has a wholly-owned subsidiary in Turkey that distributes agricultural equipment and replacement parts. On the basis of available data related to inflation indices and as a result of the devaluation of the Turkish lira relative to the United States dollar, the Turkish economy was determined to be highly inflationary during 2022. A highly inflationary economy is one where the cumulative inflation rate for the three years preceding the beginning of the reporting period, including interim reporting periods, is in excess of 100 percent. For subsidiaries operating in highly inflationary economies, the United States dollar is the functional currency. Remeasurement adjustments for financial statements in highly inflationary economies and other transactional exchange gains and losses are reported in "Other expense (income), net" within the Company's Condensed Consolidated Statements of Operations. For the nine months ended and as of September 30, 2025, the Company's wholly-owned subsidiary in Turkey had net sales of approximately $199.8 million and total assets of approximately 6.0 billion Turkish lira (or approximately $145.2 million). The monetary assets and liabilities denominated in the Turkish lira were approximately 4.5 billion Turkish lira (or approximately $107.6 million) and approximately 3.7 billion Turkish lira (or approximately $87.9 million), respectively, as of September 30, 2025. The monetary assets and liabilities were remeasured into United States dollars based on exchange rates as of September 30, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;The Company has a wholly-owned subsidiary in Argentina that assembles and distributes agricultural equipment and replacement parts. In recent years, the Argentine government has substantially limited the ability of companies to transfer funds out of Argentina. Argentina's economy was determined to be highly inflationary during 2018. In December 2023, the central bank of Argentina adjusted the official foreign currency exchange rate for the Argentine peso, significantly devaluing the currency relative to the United States dollar. For the nine months ended and as of September 30, 2025, the Company's wholly-owned subsidiary in Argentina had net sales of approximately $147.3 million and total assets of approximately 351.3 billion pesos (or approximately $259.9 million). The monetary assets of the Company's operations in Argentina denominated in pesos at the official government rate were approximately 128.0 billion pesos (or approximately $94.7 million), inclusive of approximately 74.6 billion pesos (or approximately $55.2 million) in cash and cash equivalents, as of September 30, 2025. The monetary liabilities of the Company's operations in Argentina denominated in pesos at the official government rate were approximately 29.5 billion pesos (or approximately $21.8 million) as of September 30, 2025. The monetary assets and liabilities were remeasured into United States dollar based on exchange rates as of September 30, 2025. The Company's finance joint venture in Argentina, AGCO Capital Argentina S.A. ("AGCO Capital"), had net monetary assets denominated in pesos at the official government rate of approximately 5.9 billion pesos (or approximately $4.3 million) as of September 30, 2025. All gains and losses resulting from AGCO Capital's remeasurement of its monetary assets and liabilities are reported in "Equity in net earnings of affiliates" within the Company's Condensed Consolidated Statements of Operations.

***New Accounting Pronouncements to be Adopted***

&nbsp;&nbsp;&nbsp;&nbsp;In December 2023, the FASB issued ASU 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures". The standard requires disaggregated information about a reporting entity's effective tax rate reconciliation as well as information on income taxes paid. The requirements will be effective for annual periods beginning after December 15, 2024. The guidance will be applied on a prospective basis and the Company is evaluating the option to apply the standard retrospectively. The Company plans to adopt this standard as of December 31, 2025 and it will impact only our disclosures, with no impact to our financial condition or results of operations.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

&nbsp;&nbsp;&nbsp;&nbsp;In November 2024, the FASB issued ASU 2024-03, "Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses," which requires disaggregation of certain expense captions into specified natural expense categories in the disclosures within the notes to the consolidated financial statements. In addition, the guidance requires disclosure of selling expenses and its definition. The amendments in the ASU are effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027, with early adoption permitted. The ASU will be applied prospectively with an option to simultaneously apply retrospectively. The updated standard will impact only our disclosures, with no impact to our financial condition or results of operations.

**2.&nbsp;&nbsp;&nbsp;&nbsp;ACQUISITIONS**

&nbsp;&nbsp;&nbsp;&nbsp;On September 28, 2023, the Company entered into a Sale and Contribution Agreement among AGCO, Trimble Inc. ("Trimble") and PTx Trimble, LLC ("PTx Trimble" or the "Joint Venture"), formerly known as Trimble Solutions, LLC, which was subsequently amended and restated on March 31, 2024. On April 1, 2024, pursuant to the terms of an Amended and Restated Sale and Contribution Agreement (the "Agreement"), AGCO and Trimble completed (i) the contribution by Trimble to the Joint Venture of Trimble's OneAg business ("OneAg"), which is Trimble's agricultural business, excluding certain Global Navigation Satellite System and guidance technologies, and $8.1 million of cash, (ii) the contribution by AGCO to the Joint Venture of its interest in JCA Industries, LLC d/b/a JCA Technologies and $46.0 million of cash, and (iii) the purchase by AGCO from Trimble of membership interests in the Joint Venture in exchange for the payment by AGCO to Trimble of $1,954.0 million in cash, subject to customary working capital and other adjustments. Immediately following the closing and as a result of the transaction, AGCO directly and indirectly owns an 85% interest in the Joint Venture and Trimble owns a 15% interest in the Joint Venture. The purchase price was funded using net proceeds from the issuance of Senior Notes due 2027 and 2034, a term loan facility and the remainder through other borrowings and cash on hand. Refer to Note 9 for further information. AGCO began consolidating PTx Trimble within its consolidated financial statements on April 1, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;The Company accounted for the Joint Venture transaction as a business combination using the acquisition method of accounting which requires assets acquired and liabilities assumed to be recorded at their acquisition date fair value. The Company allocated the purchase price of the acquisition to identified assets acquired, liabilities assumed, and noncontrolling interests based on their estimated fair values as of the acquisition date. The excess of the purchase price over the aggregate fair values was recorded as goodwill. The Company calculated the fair value of the assets acquired using the income, market or cost approach (or a combination thereof). Fair values of certain assets were determined based on Level 3 inputs, including estimated future cash flows, discount rates, royalty rates, growth rates and sales projections, all of which require significant management judgment and are susceptible to change. The goodwill consists of expected future economic benefits that will arise from expected future product sales, operating efficiencies and sales channel synergies that may result from the Joint Venture. The Company has deducted the portion of the goodwill balance allocated to the U.S. business for tax purposes, whereas the goodwill allocated to the Joint Venture's investments in foreign subsidiaries, primarily in Germany and France, was not deductible for tax purposes. The goodwill arising from the Joint Venture has been assigned to four new reporting units within our North America, South America, Europe/Middle East and Asia/Pacific/Africa operating segments.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

&nbsp;&nbsp;&nbsp;&nbsp;The purchase consideration transferred consisted of the following (in millions):

---

| | |
|:---|:---|
| | **Purchase Consideration** |
| Total cash consideration for OneAg | $1954.0 |
| Working capital and other adjustments | (47.1) |
| Equity transaction associated with JCA noncontrolling interest (a) | 3.1 |
| Total purchase consideration | $1910.0 |

---

*(a) Equity transaction associated with JCA noncontrolling interest*

&nbsp;&nbsp;&nbsp;&nbsp;The transfer of the 15% interest in AGCO's JCA business was accounted for as an equity transaction. The adjustment to additional paid-in-capital represents the excess of the fair value of the JCA business transferred over its historical carrying amount. The fair value of the JCA business was determined using a discounted cash flow model.

&nbsp;&nbsp;&nbsp;&nbsp;The fair values of the assets acquired, liabilities assumed and noncontrolling interests as of the acquisition date are presented in the following table (in millions):

---

| | |
|:---|:---|
| | **As of April 1, 2024** |
| Cash | $6.3 |
| Accounts receivable | 12.3 |
| Inventories | 62.6 |
| Other current assets | 6.0 |
| Property, plant and equipment | 21.6 |
| Deferred tax assets | 0.1 |
| Right-of-use lease assets | 2.4 |
| Other assets (non-current) | 0.1 |
| Intangible assets | 624.6 |
| Goodwill | 1592.2 |
| &nbsp;&nbsp;Total assets acquired | $2328.2 |
| Accounts payable | $5.8 |
| Accrued expenses | 11.2 |
| Other current liabilities | 14.0 |
| Operating lease liabilities | 1.6 |
| Deferred tax liabilities | 18.0 |
| Other noncurrent liabilities | 12.5 |
| &nbsp;&nbsp;Total liabilities assumed | $63.1 |
| Redeemable noncontrolling interests (b) | $355.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net assets acquired | $1910.0 |

---

*(b) Redeemable noncontrolling interests*

&nbsp;&nbsp;&nbsp;&nbsp;Trimble has a put option to sell its noncontrolling interests to the Company, and the Company has a call option to redeem Trimble's noncontrolling interests. The first exercisable date of both the put and call options is April 1, 2027. The put and call options prices are based on multiples of EBITDA, subject to the terms of the Agreement. We estimated the fair value of the put and call options using a Monte Carlo simulation along with a Black Scholes model assuming an exercise date of three years from the close of the transaction, the first allowable exercise date. We evaluated the put and call options for the

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

redeemable noncontrolling interests under ASC 480, Distinguishing Liabilities from Equity, and classified the redeemable noncontrolling interests as mezzanine equity based on its redemption features. The amount of the net income or loss attributable to the redeemable noncontrolling interests is recorded in "Net loss attributable to noncontrolling interests" within the Company's Condensed Consolidated Statements of Operations. To the extent the redemption value exceeds the initial fair value recorded, the Company will recognize the entire change in the redemption amount each reporting period in retained earnings.

&nbsp;&nbsp;&nbsp;&nbsp;The acquired identifiable intangible assets of OneAg as of the date of the acquisition are summarized in the following table (in millions):

---

| | | |
|:---|:---|:---|
| | **Fair Value** | **Useful Life**<sup>(1)</sup> |
| Developed Technology | $526.0 | 7 - 15 years |
| Customer Relationships | 47.3 | 20 years |
| Tradename | 6.5 | 5 years |
| Favorable contracts | 44.8 | 2 - 7 years |
|  | $624.6 |  |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Based on available information and certain assumptions that we believe were reasonable.

&nbsp;&nbsp;&nbsp;&nbsp;The following unaudited pro forma financial information presents the consolidated results of operations as if the OneAg acquisition had occurred on January 1, 2023. OneAg's pre-acquisition results have been added to the Company's historical results. The pro forma results (in millions) contained in the table below include adjustments for (i) the elimination of sales between the Company and OneAg, (ii) amortization of acquired intangible assets (iii) interest expense and amortization of debt issuance costs related to borrowings under the Senior Notes due 2027 and 2034 and term loan facility and (iv) transaction-related costs as if these had been incurred on January 1, 2023 for the period ending September 30, 2024.

---

| | | |
|:---|:---|:---|
| | **Three Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2024** | **2024** |
| Unaudited Consolidated Pro Forma Results |  |  |
| &nbsp;&nbsp;Net sales | $2599.3 | $8858.0 |
| &nbsp;&nbsp;Net income (loss) attributable to AGCO Corporation | 30.6 | (167.4) |

---

&nbsp;&nbsp;&nbsp;&nbsp;These pro forma results have been prepared for comparative purposes only and are not necessarily indicative of the results of operations as they would have been had the acquisitions occurred on the assumed dates, nor are they necessarily an indication of future operating results.

**3.&nbsp;&nbsp;&nbsp;&nbsp;BUSINESS DIVESTITURE**

&nbsp;&nbsp;&nbsp;&nbsp;On July 25, 2024, the Company entered into a Stock and Asset Purchase Agreement to sell the majority of its Grain & Protein ("G&P") business, which includes the GSI®, Automated Production® (AP), Cumberland®, Cimbria® and Tecno® brands for a purchase price of $700.0 million, subject to customary working capital and other adjustments. On November 1, 2024, the Company completed the sale of the G&P business to A-AG Holdco Limited, an affiliate of American Industrial Partners. The Company previously classified the G&P business as held for sale as of June 30, 2024. The Company determined the sale of the G&P business did not represent a strategic shift that had or will have a major effect on the consolidated results of operations, and therefore results of this business were not classified as discontinued operations. The Company received net proceeds of $630.7 million on the transaction date, which was subject to the finalization of preliminary working capital and other adjustments, and recognized a loss on the sale of business of $507.3 million. The loss on sale of business included $93.6 million of cumulative translation adjustment losses representing amounts previously recorded in accumulated other comprehensive loss. In May 2025, the preliminary working capital and other adjustments were finalized resulting in an additional loss of $12.3 million which is included within "Loss on sale of business" in the Company's Condensed Consolidated Statements of Operations. The proceeds from the sale were used to repay the Term Loan Facility and reduce borrowings under the Credit Facility in 2024. Refer to Note 9 for further information.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

&nbsp;&nbsp;&nbsp;&nbsp;The major categories of divested assets and liabilities as of the date of the divestiture were as follows (in millions):

---

| | |
|:---|:---|
| Assets divested |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $25.0 |
| &nbsp;&nbsp;&nbsp;Accounts and notes receivable, net | 170.2 |
| &nbsp;&nbsp;&nbsp;Inventories, net | 171.6 |
| &nbsp;&nbsp;&nbsp;Other current assets | 21.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 388.4 |
| Property, plant and equipment, net | 101.8 |
| Right-of-use lease assets | 15.2 |
| Other assets | 16.5 |
| Intangible assets, net | 113.7 |
| Goodwill | 203.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total assets | $839.2 |
| Liabilities divested |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $90.4 |
| &nbsp;&nbsp;&nbsp;Accrued expenses | 98.4 |
| &nbsp;&nbsp;&nbsp;Other current liabilities | 54.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities  | 243.5 |
| Deferred tax liabilities | 8.3 |
| Operating lease liabilities | 10.5 |
| Other noncurrent liabilities | 5.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $267.5 |
| Disposal group, net | $571.7 |

---

**4.&nbsp;&nbsp;&nbsp;&nbsp;ACCOUNTS RECEIVABLE SALES AGREEMENTS**

&nbsp;&nbsp;&nbsp;&nbsp;The Company has accounts receivable sales agreements that permit the sale, on an ongoing basis, of a majority of its wholesale receivables in North America, Europe and Brazil to its U.S., Canadian, European and Brazilian finance joint ventures. The cash received from receivables sold under these accounts receivable sales agreements that remain outstanding as of September 30, 2025 and December 31, 2024 was approximately $2.0 billion and $2.3 billion, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;Under the terms of the accounts receivable sales agreements in the U.S., Canada, Europe and Brazil, the Company pays an annual fee related to the servicing of the receivables sold. The Company also pays the respective AGCO Finance entities a subsidized interest payment with respect to the accounts receivable sales agreements, calculated based upon the interest rate charged by Rabobank to its affiliate, and such affiliate then lends to the AGCO Finance entities plus an agreed-upon margin. These fees are reflected within losses on the sales of receivables included within "Other expense (income), net" in the Company's Condensed Consolidated Statements of Operations. The Company does not service the receivables after the sale occurs and does not maintain any direct retained interest in the receivables. The Company reviewed its accounting for the accounts receivable sales agreements and determined that receivables sold under these agreements should be accounted for as off-balance sheet transactions.

&nbsp;&nbsp;&nbsp;&nbsp;In addition, the Company sells certain trade receivables under factoring arrangements to other financial institutions around the world. The cash received from trade receivables sold under factoring arrangements that remain outstanding as of September 30, 2025 and December 31, 2024 was approximately $252.7 million and $220.5 million, respectively. Under these arrangements, the Company is required to continue to service the sold receivables at market rates. The Company does not maintain any direct retained interest in the receivables. The Company reviewed its accounting for the accounts receivable sales

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

agreements and determined that receivables sold under these agreements should be accounted for as off-balance sheet transactions.

&nbsp;&nbsp;&nbsp;&nbsp;Losses on sales of receivables associated with the accounts receivable sales agreements discussed above, reflected within "Other expense (income), net" in the Company's Condensed Consolidated Statements of Operations, were approximately $21.9 million and $60.6 million during the three and nine months ended September 30, 2025, respectively. Losses on sales of receivables associated with the accounts receivable sales agreements discussed above, reflected within "Other expense (income), net" in the Company's Condensed Consolidated Statements of Operations, were approximately $28.4 million and $92.2 million during the three and nine months ended September 30, 2024, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;The Company's finance joint ventures in Europe, Brazil and Australia also provide wholesale financing directly to the Company's dealers. As of September 30, 2025 and December 31, 2024, these finance joint ventures had approximately $87.1 million and $139.2 million, respectively, of outstanding accounts receivable associated with these arrangements.

&nbsp;&nbsp;&nbsp;&nbsp;In certain foreign countries, the Company invoices its finance joint ventures directly and the finance joint ventures retain a form of title to the goods delivered to dealers until the dealer makes payment so that the finance joint ventures can recover the goods in the event of dealer or end customer default on payment. This occurs as the laws of some foreign countries do not provide for a seller's retention of a security interest in goods in the same manner as established in the United States Uniform Commercial Code. The only right the finance joint ventures retain with respect to the title are those enabling recovery of the goods in the event of customer default on payment. The dealer or distributor may not return equipment or replacement parts to the Company while its contract with the finance joint venture is in force, and can only return the equipment to the retail finance joint venture with penalties that would generally not make it economically beneficial to do so.

**5.&nbsp;&nbsp;&nbsp;&nbsp;GOODWILL AND OTHER INTANGIBLE ASSETS**

&nbsp;&nbsp;&nbsp;&nbsp;Changes in the carrying amount of goodwill during the nine months ended September 30, 2025 are summarized as follows (in millions):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **North America** | **South America** | **Europe/Middle East** | **Asia/Pacific/Africa** | **Consolidated** |
| Balance as of December 31, 2024 | $742.8 | $94.9 | $962.3 | $20.4 | $1820.4 |
| Foreign currency translation | 1.0 | 10.4 | 69.4 |  | 80.8 |
| Balance as of September 30, 2025 | $743.8 | $105.3 | $1031.7 | $20.4 | $1901.2 |

---

&nbsp;&nbsp;&nbsp;&nbsp;Goodwill is tested for impairment on an annual basis and more often if indications of impairment exist. The Company conducts its annual impairment analyses as of October 1<sup>st</sup> each year.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

&nbsp;&nbsp;&nbsp;&nbsp;Changes in the carrying amount of acquired intangible assets during the nine months ended September 30, 2025 are summarized as follows (in millions):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **<u>Gross carrying amounts:</u>** | **Trademarks and Trade Names** | **Customer Relationships** | **Patents and Technology** | **Other** | **Total** |
| Balance as of December 31, 2024 | $75.1 | $179.1 | $604.7 | $50.9 | $909.8 |
| Impairment charge | (1.6) |  | (0.6) |  | (2.2) |
| Foreign currency translation | 2.1 | 12.7 | 16.8 | 0.2 | 31.8 |
| Balance as of September 30, 2025 | $75.6 | $191.8 | $620.9 | $51.1 | $939.4 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **<u>Accumulated amortization:</u>** | **Trademarks and Trade Names** | **Customer Relationships** | **Patents and Technology** | **Other** | **Total** |
| Balance as of December 31, 2024 | $45.6 | $109.6 | $95.0 | $14.9 | $265.1 |
| Amortization expense | 3.1 | 5.3 | 41.7 | 3.9 | 54.0 |
| Impairment charge | (1.2) |  | (0.4) |  | (1.6) |
| Foreign currency translation | 2.0 | 10.8 | 7.0 | 0.1 | 19.9 |
| Balance as of September 30, 2025 | $49.5 | $125.7 | $143.3 | $18.9 | $337.4 |

---

---

| | |
|:---|:---|
| **<u>Indefinite-lived intangible assets:</u>** | **Trademarks and Trade Names** |
| Balance as of December 31, 2024 | $83.8 |
| Foreign currency translation | 4.0 |
| Balance as of September 30, 2025 | $87.8 |

---

&nbsp;&nbsp;&nbsp;&nbsp;The Company amortizes certain acquired identifiable intangible assets primarily on a straight-line basis over their estimated useful lives, which range from three to 50 years. External-use software, net, developed by the Company and marketed externally, was approximately $0.4 million as of December 31, 2024 and classified within "Intangible assets, net."

**6.&nbsp;&nbsp;&nbsp;&nbsp;INVENTORIES**

&nbsp;&nbsp;&nbsp;&nbsp;Inventories, net at September 30, 2025 and December 31, 2024, were as follows (in millions):

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Finished goods | $1263.8 | $1187.9 |
| Repair and replacement parts | 841.2 | 754.6 |
| Work in process | 255.0 | 170.0 |
| Raw materials | 721.1 | 618.8 |
| Inventories, net | $3081.1 | $2731.3 |

---

&nbsp;&nbsp;&nbsp;&nbsp;At September 30, 2025 and December 31, 2024, the Company had recorded $272.0 million and $251.1 million respectively, as a reserve for surplus and obsolete inventories. These reserves are reflected within "Inventories, net" within the Company's Condensed Consolidated Balance Sheets.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

**7.&nbsp;&nbsp;&nbsp;&nbsp;PRODUCT WARRANTY**

&nbsp;&nbsp;&nbsp;&nbsp;The warranty reserve activity for the three and nine months ended September 30, 2025 and 2024, including deferred revenue associated with the Company's extended warranties that have been sold, was as follows (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Balance at beginning of period | $801.0 | $774.6 | $743.0 | $800.8 |
| Acquisitions |  |  |  | 4.1 |
| Accruals for warranties issued | 119.4 | 106.8 | 299.5 | 292.7 |
| Settlements made and deferred revenue recognized  | (111.1) | (116.2) | (307.2) | (291.8) |
| Reclassified to held for sale<sup>(1)</sup> |  | (0.3) |  | (11.9) |
| Foreign currency translation | 1.1 | 27.9 | 75.1 | (1.1) |
| Balance at September 30 | $810.4 | $792.8 | $810.4 | $792.8 |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Reclassification resulting from the Company's classification of the majority of the Grain & Protein ("G&P") business as held for sale as of June 30, 2024. The Company divested the majority of its G&P business on November 1, 2024. Refer to Note 3 for additional information.

&nbsp;&nbsp;&nbsp;&nbsp;The Company's agricultural equipment products generally are warranted against defects in material and workmanship for a period of one to four years. The Company accrues for future warranty costs at the time of sale based on historical warranty experience. The Company's extended warranty period for the majority of products ranges from three to five years. Revenue is recognized for the extended warranty contracts on a straight-line basis, which the Company believes approximates the cost expected to be incurred in satisfying the obligations, over the extended warranty period. Approximately $623.8 million, $598.7 million and $645.2 million of warranty reserves are included in "Accrued expenses" in the Company's Condensed Consolidated Balance Sheets as of September 30, 2025, December 31, 2024 and September 30, 2024, respectively. Approximately $186.6 million, $144.3 million and $147.6 million of warranty reserves are included in "Other noncurrent liabilities" in the Company's Condensed Consolidated Balance Sheets as of September 30, 2025, December 31, 2024 and September 30, 2024, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;The Company recognizes potential recoveries of the costs associated with warranties it provides when the collection is probable. When specifics of the recovery have been agreed upon with the Company's suppliers through the confirmation of liability for the recovery, the Company records the recovery within "Accounts and notes receivable, net" in the Company's Condensed Consolidated Balance Sheets. Estimates of the amount of warranty claim recoveries to be received from the Company's suppliers based upon contractual supplier arrangements are recorded within "Other current assets" in the Company's Condensed Consolidated Balance Sheets.

**8.&nbsp;&nbsp;&nbsp;&nbsp;SUPPLIER FINANCE PROGRAMS**

&nbsp;&nbsp;&nbsp;&nbsp;The Company has supplier financing arrangements with certain banks or other intermediaries whereby a bank or intermediary purchases receivables held by the Company's suppliers. Under the program, suppliers have the option to be paid by the bank or intermediary earlier than the payment due date. When the supplier receives an early payment, they receive discounted amounts, and the Company pays the bank or intermediary the face amount of the invoice on the payment due date. The Company does not reimburse suppliers for any costs incurred for participation in the program. The Company and its suppliers agree on the contractual terms, including prices, quantities and payment terms, regardless of whether the supplier elects to participate in the supplier finance programs. The suppliers' voluntary inclusion in the supplier financing programs has no bearing on the Company's payment terms. The Company has no economic interest in a supplier's decision to participate in the programs, and the Company has no direct financial relationship with the banks or other intermediaries as it relates to the supplier finance programs. As of September 30, 2025, payment terms with the majority of the Company's suppliers are 30 to 180 days, which correspond to the contractual terms, with rates that are based on market rates (such as SOFR) plus a credit spread. There are no assets pledged as security under the programs. As of September 30, 2025 and December 31, 2024, the amounts outstanding that remain unpaid to the banks or other intermediaries totaled $34.3 million and $50.6 million, respectively, and are reflected in "Accounts payable" in the Company's Condensed Consolidated Balance Sheets.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

**9.&nbsp;&nbsp;&nbsp;&nbsp;INDEBTEDNESS**

&nbsp;&nbsp;&nbsp;&nbsp;Long-term debt consisted of the following at September 30, 2025 and December 31, 2024 (in millions):

---

| | | |
|:---|:---|:---|
| | **September 30, 2025** | **December 31, 2024** |
| Credit Facility, expires 2027 | $350 | $— |
| 5.450% Senior notes due 2027 | 400.0 | 400.0 |
| 5.800% Senior notes due 2034 | 700.0 | 700.0 |
| 0.800% Senior notes due 2028 | 704.0 | 622.7 |
| 1.002% EIB Senior term loan due 2025 |  | 259.5 |
| EIB Senior term loan due 2029 | 293.3 | 259.5 |
| EIB Senior term loan due 2030 | 199.5 | 176.4 |
| Senior term loans due between 2025 and 2028 | 98.0 | 152.0 |
| Debt issuance costs | (10.4) | (12.0) |
|  | 2734.4 | 2558.1 |
| Less: |  |  |
| &nbsp;&nbsp;1.002% EIB Senior term loan due 2025 |  | (259.5) |
| &nbsp;&nbsp;Senior term loans due 2025 |  | (65.3) |
| Total long-term indebtedness | $2734.4 | $2233.3 |

---

***Credit Facility***

&nbsp;&nbsp;&nbsp;&nbsp;The Company has a credit facility providing for a $1.25 billion multi-currency unsecured revolving credit facility ("Credit Facility") that matures on December 19, 2027. In May 2025, the Company amended the Credit Facility with respect to the net leverage ratio financial covenant requirements for the remainder of 2025 and in the event of a future material acquisition. As of September 30, 2025, the Company had $350.0 million in outstanding borrowings under the revolving credit facility and had the ability to borrow $900.0 million.

***Uncommitted Credit Facility***

&nbsp;&nbsp;&nbsp;&nbsp;The Company has an uncommitted revolving credit facility that allows the Company to borrow up to €200.0 million (or approximately $234.7 million as of September 30, 2025). The credit facility expires on December 31, 2026. As of September 30, 2025 and December 31, 2024, the Company had no outstanding borrowings under the revolving credit facility.

***1.002% European Investment Bank (*"*EIB*"*) Senior Term Loan due 2025***

&nbsp;&nbsp;&nbsp;&nbsp;On January 24, 2025, the Company repaid €250.0 million (or approximately $262.3 million) upon maturity of the EIB Senior term loan due 2025.

***Senior Term Loans due between 2025 and 2028***

&nbsp;&nbsp;&nbsp;&nbsp;In August 2025, the Company repaid €63.0 million (or approximately $72.8 million) upon maturity of the Senior term loans due 2025.

***Other Short-Term Borrowings***

&nbsp;&nbsp;&nbsp;&nbsp;As of September 30, 2025 and December 31, 2024, the Company had short-term borrowings due within one year, excluding the current portion of long-term debt, of approximately $109.2 million and $90.4 million, respectively.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

***Standby Letters of Credit and Similar Instruments***

&nbsp;&nbsp;&nbsp;&nbsp;The Company has arrangements with various banks to issue standby letters of credit or similar instruments, which guarantee the Company's obligations for the purchase or sale of certain inventories and for potential claims exposure for insurance coverage. At September 30, 2025 and December 31, 2024, outstanding letters of credit totaled approximately $13.6 million and $13.2 million, respectively.

**10.&nbsp;&nbsp;&nbsp;&nbsp;RESTRUCTURING AND BUSINESS OPTIMIZATION EXPENSES**

***Restructuring Expenses***

&nbsp;&nbsp;&nbsp;&nbsp;On June 24, 2024, the Company announced a restructuring program (the "Program") in response to increased weakening demand in the agriculture industry. The Company estimates that it will incur charges for one-time termination benefits of approximately $150.0 million to $200.0 million in connection with the initial phase of the Program, primarily consisting of cash charges related to severance payments, employees benefits and related costs. The Company incurred the majority of charges in 2024 and expects to incur the remaining charges in 2025.

&nbsp;&nbsp;&nbsp;&nbsp;Restructuring expenses activity, which relates to severance and other related costs, during the three and nine months ended September 30, 2025, is summarized as follows (in millions):

---

| | |
|:---|:---|
| Balance as of December 31, 2024 | $136.2 |
| First quarter 2025 provision, net of reversals | (0.8) |
| First quarter 2025 cash activity | (30.3) |
| Foreign currency translation | 4.4 |
| Balance as of March 31, 2025 | $109.5 |
| Second quarter 2025 provision, net of reversals | 2.5 |
| Second quarter 2025 cash activity | (39.4) |
| Foreign currency translation | 7.3 |
| Balance as of June 30, 2025 | $79.9 |
| Third quarter 2025 provision, net of reversals | 4.2 |
| Third quarter 2025 cash activity | (30.8) |
| Foreign currency translation |  |
| Balance as of September 30, 2025 | $53.3 |

---

&nbsp;&nbsp;&nbsp;&nbsp;Approximately $41.6 million and $125.2 million of restructuring expenses are included in "Accrued expenses" in the Company's Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024, respectively. Approximately $11.7 million and $11.0 million of restructuring expenses are included in "Other noncurrent liabilities" in the Company's Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024, respectively.

***Business Optimization Expenses***

&nbsp;&nbsp;&nbsp;&nbsp;Business optimization expenses primarily relate to professional services costs incurred as part of the restructuring program aimed at reducing structural costs, enhancing global efficiencies by changing the Company's operating model for certain corporate and back-office functions. During the three and nine months ended September 30, 2025, the Company recognized approximately $4.5 million and $31.4 million, respectively, of business optimization expenses.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

**11.&nbsp;&nbsp;&nbsp;&nbsp;DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES**

***Derivative Transactions Designated as Hedging Instruments***

**Cash Flow Hedges**

*Foreign Currency Contracts*

&nbsp;&nbsp;&nbsp;&nbsp;The Company uses cash flow hedges to minimize the variability in cash flows of assets or liabilities or forecasted transactions caused by fluctuations in foreign currency exchange rates. The changes in the fair values of these cash flow hedges are recorded in accumulated other comprehensive loss and are subsequently reclassified into "Cost of goods sold" during the period the sales and purchases are recognized. These amounts offset the effect of the changes in foreign currency rates on the related sale and purchase transactions.

&nbsp;&nbsp;&nbsp;&nbsp;The Company designates certain foreign currency contracts as cash flow hedges of expected future sales and purchases. The total notional value of derivatives that were designated as cash flow hedges was approximately $168.7 million and $356.7 million as of September 30, 2025 and December 31, 2024, respectively.

*Steel Commodity Contracts*

&nbsp;&nbsp;&nbsp;&nbsp;The Company designates certain steel commodity contracts as cash flow hedges of expected future purchases of steel. The Company did not have any derivatives that were designated as cash flow hedges related to steel commodity contracts as of September 30, 2025 and December 31, 2024, respectively.

*Interest Rate Risk*

&nbsp;&nbsp;&nbsp;&nbsp;The Company entered into treasury rate locks in early March 2024 to fix the interest rate for the 5.800% Senior Notes due 2034 (the "2034 Notes") issued on March 21, 2024. The derivative position settled on March 28, 2024 with a cash settlement that offset changes in the benchmark treasury rate between the execution of the treasury rate lock and the debt pricing date for the 2034 Notes. This treasury rate lock was designated as a cash flow hedge and the gain at termination of $8.2 million was recognized in accumulated other comprehensive loss. The amount recognized in accumulated other comprehensive loss is reclassified to interest expense as interest payments are made on the 2034 Notes through the maturity date.

&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes the activity in accumulated other comprehensive loss related to the derivatives held by the Company during the three months ended September 30, 2025 (in millions):

---

| | | | |
|:---|:---|:---|:---|
| | **Before-Tax Amount** | **Income Tax Expense (Benefit)** | **After-Tax Amount** |
| Accumulated derivative net gains as of June 30, 2025 | $11.5 | $2.4 | $9.1 |
| Net changes in fair value of derivatives |  |  |  |
| &nbsp;&nbsp;Foreign currency contracts<sup>(1)</sup> | (1.4) | (0.2) | (1.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | (1.4) | (0.2) | (1.2) |
| Net gains reclassified from accumulated other comprehensive loss into income |  |  |  |
| &nbsp;&nbsp;Foreign currency contracts<sup>(1)</sup>  | (3.2) | (0.6) | (2.6) |
| &nbsp;&nbsp;Treasury rate locks | (0.2) | (0.1) | (0.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | (3.4) | (0.7) | (2.7) |
| Accumulated derivative net gains as of September 30, 2025 | $6.7 | $1.5 | $5.2 |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;The outstanding contracts as of September 30, 2025 range in maturity through December 2025.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

&nbsp;&nbsp;&nbsp;&nbsp;As of September 30, 2025, approximately $0.7 million of realized derivative net gains, before taxes, remain in accumulated other comprehensive loss related to foreign currency contracts associated with inventory that had not yet been sold.

&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes the activity in accumulated other comprehensive loss related to the derivatives held by the Company during the three months ended September 30, 2024 (in millions):

---

| | | | |
|:---|:---|:---|:---|
| | **Before-Tax Amount** | **Income Tax Expense (Benefit)** | **After-Tax Amount** |
| Accumulated derivative net gains as of June 30, 2024 | $6.8 | $2.7 | $4.1 |
| Net changes in fair value of derivatives |  |  |  |
| &nbsp;&nbsp;Foreign currency contracts | (0.1) | 0.2 | (0.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | (0.1) | 0.2 | (0.3) |
| Net losses (gains) reclassified from accumulated other comprehensive loss into income |  |  |  |
| &nbsp;&nbsp;Foreign currency contracts | 2.2 | 0.3 | 1.9 |
| &nbsp;&nbsp;Commodity contracts | 0.1 |  | 0.1 |
| &nbsp;&nbsp;Treasury rate locks | (0.2) | (0.1) | (0.1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 2.1 | 0.2 | 1.9 |
| Accumulated derivative net gains as of September 30, 2024 | $8.8 | $3.1 | $5.7 |

---

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes the activity in accumulated other comprehensive loss related to the derivatives held by the Company during the nine months ended September 30, 2025 (in millions):

---

| | | | |
|:---|:---|:---|:---|
| | **Before-Tax Amount** | **Income Tax Expense (Benefit)** | **After-Tax Amount** |
| Accumulated derivative net gains as of December 31, 2024 | $11.7 | $2.8 | $8.9 |
| Net changes in fair value of derivatives |  |  |  |
| &nbsp;&nbsp;Foreign currency contracts<sup>(1)</sup> | 2.5 | 0.6 | 1.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 2.5 | 0.6 | 1.9 |
| Net gains reclassified from accumulated other comprehensive loss into income |  |  |  |
| &nbsp;&nbsp;Foreign currency contracts<sup>(1)</sup>  | (6.9) | (1.7) | (5.2) |
| &nbsp;&nbsp;Treasury rate locks | (0.6) | (0.2) | (0.4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | (7.5) | (1.9) | (5.6) |
| Accumulated derivative net gains as of September 30, 2025 | $6.7 | $1.5 | $5.2 |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;The outstanding contracts as of September 30, 2025 range in maturity through December 2025.

&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes the activity in accumulated other comprehensive loss related to the derivatives held by the Company during the nine months ended September 30, 2024 (in millions):

---

| | | | |
|:---|:---|:---|:---|
| | **Before-Tax Amount** | **Income Tax Expense (Benefit)** | **After-Tax Amount** |
| Accumulated derivative net losses as of December 31, 2023 | $(1.3) | $(0.5) | $(0.8) |
| Net changes in fair value of derivatives |  |  |  |
| &nbsp;&nbsp;Foreign currency contracts | (4.0) | 1.0 | (5.0) |
| &nbsp;&nbsp;Commodity contracts | (0.3) |  | (0.3) |
| &nbsp;&nbsp;Treasury rate locks | 8.2 | 2.1 | 6.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total | 3.9 | 3.1 | 0.8 |
| Net losses (gains) reclassified from accumulated other comprehensive loss into income |  |  |  |
| &nbsp;&nbsp;Foreign currency contracts | 6.4 | 0.7 | 5.7 |
| &nbsp;&nbsp;Commodity contracts | 0.3 |  | 0.3 |
| &nbsp;&nbsp;Treasury rate locks | (0.5) | (0.2) | (0.3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 6.2 | 0.5 | 5.7 |
| Accumulated derivative net gains as of September 30, 2024 | $8.8 | $3.1 | $5.7 |

---

**Net Investment Hedges**

&nbsp;&nbsp;&nbsp;&nbsp;The Company uses non-derivative and derivative instruments to hedge a portion of its net investment in foreign operations against adverse movements in exchange rates. For instruments that are designated as hedges of net investments in foreign operations, changes in the fair value of the derivative instruments are recorded in foreign currency translation adjustments, a component of accumulated other comprehensive loss, to offset changes in the value of the net investments being hedged. When the net investment in foreign operations is sold or substantially liquidates, the amounts recorded in accumulated other comprehensive loss are reclassified to earnings. To the extent foreign currency denominated debt is de-designated from a net investment hedge relationship, changes in the value of the foreign currency denominated debt are recorded in earnings through the maturity date.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

&nbsp;&nbsp;&nbsp;&nbsp;On January 29, 2021, the Company entered into a cross currency swap contract as a hedge of its net investment in foreign operations to offset foreign currency translation gains or losses on the net investment. The cross currency swap had an expiration date of January 29, 2028. At maturity of the cross currency swap contract, the Company was expected to deliver the notional amount of approximately €247.9 million and receive $300.0 million from the counterparties. The Company received quarterly interest payments from the counterparties based on a fixed interest rate until the maturity of the cross currency swap. On November 4, 2024, the Company's existing cross currency swap contract was terminated and the Company delivered the notional amount of approximately $277.4 million and received $300.0 million from the counterparties, resulting in a gain of approximately $22.6 million that was recognized in accumulated other comprehensive loss.

&nbsp;&nbsp;&nbsp;&nbsp;On November 4, 2024, the Company entered into new $600.0 million cross currency swap contracts comprising a $200.0 million tranche for three years tenor, $200.0 million tranche for five years tenor and $200.0 million tranche for seven years tenor as a hedge of its net investment in foreign operations to offset foreign currency translation gains or losses on the net investment. The cross currency swap contracts have an expiration date of November 6, 2027, November 6, 2029 and November 6, 2031, respectively. At maturity of the cross currency swap contracts, the Company is expected to deliver the notional amount of approximately €385.5 million (or approximately $452.3 million as of September 30, 2025) and Fr.155.5 million (or approximately $195.1 million as of September 30, 2025), respectively, and receive $600.0 million from the counterparties. The Company receives quarterly interest payments from the counterparties based on a fixed interest rate until maturity of the cross currency swap.

&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes the notional values of the instrument designated as a net investment hedge (in millions):

---

| | | |
|:---|:---|:---|
| | **Notional Amount as of** | **Notional Amount as of** |
| | **September 30, 2025** | **December 31, 2024** |
| Cross currency swap contracts | $600.0 | $600.0 |

---

&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes the changes in the fair value of the cross currency swap contracts designated as a net investment hedge during the three months and nine months ended September 30, 2025 and 2024 (in millions):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Gain (Loss) Recognized in Other Comprehensive Income for the**<br>**Three Months Ended** | **Gain (Loss) Recognized in Other Comprehensive Income for the**<br>**Three Months Ended** | **Gain (Loss) Recognized in Other Comprehensive Income for the**<br>**Three Months Ended** | **Gain (Loss) Recognized in Other Comprehensive Income (Loss) for the** <br>**Nine Months Ended** | **Gain (Loss) Recognized in Other Comprehensive Income (Loss) for the** <br>**Nine Months Ended** | **Gain (Loss) Recognized in Other Comprehensive Income (Loss) for the** <br>**Nine Months Ended** |
| | **Before-Tax Amount** | **Income Tax Expense (Benefit)** | **After-Tax Amount** | **Before-Tax Amount** | **Income Tax Expense (Benefit)** | **After-Tax Amount** |
| September 30, 2025 | $0.7 | $0.2 | $0.5 | $(58.6) | $(15.1) | $(43.5) |
| September 30, 2024 | (7.1) | (1.8) | (5.3) | 1.0 | 0.2 | 0.8 |

---

***Derivative Transactions Not Designated as Hedging Instruments***

&nbsp;&nbsp;&nbsp;&nbsp;The Company enters into foreign currency contracts to economically hedge a portion of its receivables and payables on the Company and its subsidiaries' balance sheets that are denominated in foreign currencies other than the functional currency. These contracts are classified as non-designated derivative instruments. Gains and losses on such contracts are substantially offset by losses and gains on the remeasurement of the underlying asset or liability being hedged and are immediately recognized into earnings. As of September 30, 2025 and December 31, 2024, the Company had outstanding foreign currency contracts with a notional amount of approximately $2,608.9 million and $3,231.2 million, respectively.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes the results on net income (loss) of derivatives not designated as hedging instruments (in millions):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Gain (Loss) Recognized in Net Income for the Three Months Ended** | **Gain (Loss) Recognized in Net Income for the Three Months Ended** | **Gain (Loss) Recognized in Net Income (Loss) for the Nine Months Ended** | **Gain (Loss) Recognized in Net Income (Loss) for the Nine Months Ended** |
| |<br>**Classification of Gain (Loss)** | **September 30, 2025** | **September 30, 2024** | **September 30, 2025** | **September 30, 2024** |
| Foreign currency contracts | Other expense (income), net | $(11.6) | $17.1 | $32.3 | $(24.7) |

---

&nbsp;&nbsp;&nbsp;&nbsp;The table below sets forth the fair value of derivative instruments as of September 30, 2025 (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Asset Derivatives as of** <br>**September 30, 2025** | **Asset Derivatives as of** <br>**September 30, 2025** | **Liability Derivatives as of** <br>**September 30, 2025** | **Liability Derivatives as of** <br>**September 30, 2025** |
| | **Balance Sheet Location** | **Fair Value** | **Balance Sheet Location** | **Fair Value** |
| Derivative instruments designated as hedging instruments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts | Other current assets | $2.6 | Other current liabilities | $2.2 |
| &nbsp;&nbsp;Cross currency swap contracts | Other noncurrent assets |  | Other noncurrent liabilities | 42.4 |
| Derivative instruments not designated as hedging instruments: |  |  |  |  |
| &nbsp;&nbsp;Foreign currency contracts<sup>(1)</sup> | Other current assets | 1.9 | Other current liabilities | 6.3 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total derivative instruments |  | $4.5 |  | $50.9 |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;The outstanding contracts as of September 30, 2025 range in maturity through November 2025.

&nbsp;&nbsp;&nbsp;&nbsp;The table below sets forth the fair value of derivative instruments as of December 31, 2024 (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Asset Derivatives as of** <br>**December 31, 2024** | **Asset Derivatives as of** <br>**December 31, 2024** | **Liability Derivatives as of** <br>**December 31, 2024** | **Liability Derivatives as of** <br>**December 31, 2024** |
| | **Balance Sheet Location** | **Fair Value** | **Balance Sheet Location** | **Fair Value** |
| Derivative instruments designated as hedging instruments: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts | Other current assets | $3.7 | Other current liabilities | $1.6 |
| &nbsp;&nbsp;&nbsp;Commodity contracts | Other current assets |  | Other current liabilities |  |
| &nbsp;&nbsp;Cross currency swap contracts | Other noncurrent assets | 16.2 | Other noncurrent liabilities |  |
| Derivative instruments not designated as hedging instruments: |  |  |  |  |
| &nbsp;&nbsp;Foreign currency contracts | Other current assets | 26.1 | Other current liabilities | 12.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total derivative instruments |  | $46.0 |  | $14.2 |

---

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

**12.&nbsp;&nbsp;&nbsp;&nbsp;STOCKHOLDERS' EQUITY**

**&nbsp;&nbsp;&nbsp;&nbsp;**The following tables set forth changes in redeemable noncontrolling interests and stockholders' equity attributed to AGCO Corporation and to noncontrolling interests for the three and nine months ended September 30, 2025 and 2024 (in millions):

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Redeemable Noncontrolling Interests** | **Common<br>Stock** | **Additional<br>Paid-in Capital** | **Retained<br>Earnings** | **Accumulated Other<br>Comprehensive Loss** | **Total Stockholders'<br>Equity** |
| Balance, June 30, 2025 | $304.3 | $0.7 | $10.0 | $5922.6 | $(1764.8) | $4168.5 |
| Stock compensation |  |  | 7.2 |  |  | 7.2 |
| Issuance of stock awards |  |  | (1.1) |  |  | (1.1) |
| SSARs exercised |  |  | (0.1) |  |  | (0.1) |
| Comprehensive income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | (3.0) |  |  | 305.7 |  | 305.7 |
| Other comprehensive income (loss): |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustments |  |  |  |  | 34.0 | 34.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defined pension and postretirement benefit plans, net of tax |  |  |  |  | 2.1 | 2.1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred gains and losses on derivatives, net of tax |  |  |  |  | (3.9) | (3.9) |
| Payment of dividends to stockholders |  |  |  | (21.6) |  | (21.6) |
| Balance, September 30, 2025 | $301.3 | $0.7 | $16.0 | $6206.7 | $(1732.6) | $4490.8 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Redeemable Noncontrolling Interests** | **Common<br>Stock** | **Additional<br>Paid-in Capital** | **Retained<br>Earnings** | **Accumulated Other<br>Comprehensive Loss** | **Total Stockholders'<br>Equity** |
| Balance, December 31, 2024 | $300.1 | $0.7 | $— | $5645.0 | $(1902.9) | $3742.8 |
| Stock compensation |  |  | 23.0 |  |  | 23.0 |
| Issuance of stock awards |  |  | (6.9) | (4.4) |  | (11.3) |
| SSARs exercised |  |  | (0.1) |  |  | (0.1) |
| Comprehensive income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | (5.2) |  |  | 631.0 |  | 631.0 |
| Other comprehensive income (loss): |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | 6.4 |  |  |  | 168.0 | 168.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defined pension and postretirement benefit plans, net of tax |  |  |  |  | 6.0 | 6.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred gains and losses on derivatives, net of tax |  |  |  |  | (3.7) | (3.7) |
| Payment of dividends to stockholders |  |  |  | (64.9) |  | (64.9) |
| Balance, September 30, 2025 | $301.3 | $0.7 | $16.0 | $6206.7 | $(1732.6) | $4490.8 |

---

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Redeemable Noncontrolling Interests** | **Common<br>Stock** | **Additional<br>Paid-in Capital** | **Retained<br>Earnings** | **Accumulated Other<br>Comprehensive Loss** | **Noncontrolling<br>Interests** | **Total Stockholders'<br>Equity** |
| Balance, June 30, 2024 | $504.7 | $0.7 | $9.2 | $5930.6 | $(1886.7) | $0.1 | $4053.9 |
| Stock compensation |  |  | 3.8 |  |  |  | 3.8 |
| Issuance of stock awards |  |  | (0.6) | (0.1) |  |  | (0.7) |
| Sale of minority interest |  |  |  |  |  | (0.1) | (0.1) |
| Comprehensive income: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | (1.1) |  |  | 30.0 |  |  | 30.0 |
| Other comprehensive income: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | 1.1 |  |  |  | 79.9 |  | 79.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defined pension and postretirement benefit plans, net of tax |  |  |  |  | 2.0 |  | 2.0 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred gains and losses on derivatives, net of tax |  |  |  |  | 1.6 |  | 1.6 |
| Payment of dividends to stockholders |  |  |  | (21.6) |  |  | (21.6) |
| Redeemable noncontrolling interests measurement period adjustment (Note 2) | (167.2) |  |  |  |  |  |  |
| Balance, September 30, 2024 | $337.5 | $0.7 | $12.4 | $5938.9 | $(1803.2) | $— | $4148.8 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Redeemable Noncontrolling Interests** | **Common<br>Stock** | **Additional<br>Paid-in Capital** | **Retained<br>Earnings** | **Accumulated Other<br>Comprehensive Loss** | **Noncontrolling<br>Interests** | **Total Stockholders'<br>Equity** |
| Balance, December 31, 2023 | $— | $0.7 | $4.1 | $6360.0 | $(1708.1) | $0.1 | $4656.8 |
| Stock compensation |  |  | 18.6 |  |  |  | 18.6 |
| Issuance of stock awards |  |  | (13.3) | (0.5) |  |  | (13.8) |
| SSARs exercised |  |  | (0.1) |  |  |  | (0.1) |
| Sale of minority interest |  |  |  |  |  | (0.1) | (0.1) |
| Comprehensive loss: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net loss | (2.9) |  |  | (169.1) |  |  | (169.1) |
| Other comprehensive income (loss): |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | 0.1 |  |  |  | (107.2) |  | (107.2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defined pension and postretirement benefit plans, net of tax |  |  |  |  | 5.6 |  | 5.6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred gains and losses on derivatives, net of tax |  |  |  |  | 6.5 |  | 6.5 |
| Payment of dividends to stockholders |  |  |  | (251.5) |  |  | (251.5) |
| Equity transaction associated with JCA noncontrolling interest (Note 2) |  |  | 3.1 |  |  |  | 3.1 |
| Initial fair value of redeemable noncontrolling interests (Note 2) | 332.2 |  |  |  |  |  |  |
| Investment by redeemable noncontrolling interest (Note 2) | 8.1 |  |  |  |  |  |  |
| Balance, September 30, 2024 | $337.5 | $0.7 | $12.4 | $5938.9 | $(1803.2) | $— | $4148.8 |

---

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth changes in accumulated other comprehensive loss by component, net of tax, attributed to AGCO Corporation for the nine months ended September 30, 2025 (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Defined Pension and Postretirement Benefit Plans**  | **Deferred Gains and Losses on Derivatives** | **Cumulative Translation Adjustment** | **Total** |
| Accumulated other comprehensive loss, <br>December 31, 2024 | $(218.8) | $8.9 | $(1693.0) | $(1902.9) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income before reclassifications |  | 1.9 | 168.0 | 169.9 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net losses (gains) reclassified from accumulated other comprehensive loss | 6.0 | (5.6) |  | 0.4 |
| Other comprehensive income | 6.0 | (3.7) | 168.0 | 170.3 |
| Accumulated other comprehensive loss, <br>September 30, 2025 | $(212.8) | $5.2 | $(1525.0) | $(1732.6) |

---

&nbsp;&nbsp;&nbsp;&nbsp;The following tables set forth reclassification adjustments out of accumulated other comprehensive loss by component attributed to AGCO Corporation for the three and nine months ended September 30, 2025 and 2024 (in millions):

---

| | | | |
|:---|:---|:---|:---|
| | **Amount Reclassified from Accumulated Other Comprehensive Loss** | **Amount Reclassified from Accumulated Other Comprehensive Loss** | **Affected Line Item within the Condensed Consolidated <br>Statements of Operations** |
|<br>**Details about Accumulated Other Comprehensive Loss Components** | **Three Months Ended September 30, 2025**<sup>(1)</sup> | **Three Months Ended September 30, 2024**<sup>(1)</sup> | **Affected Line Item within the Condensed Consolidated <br>Statements of Operations** |
| Derivatives: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net losses (gains) on foreign currency contracts | $(3.2) | $2.2 | Cost of goods sold |
| &nbsp;&nbsp;&nbsp;&nbsp;Net losses on commodity contracts |  | 0.1 | Cost of goods sold |
| &nbsp;&nbsp;&nbsp;&nbsp;Net gains on treasury rate locks | (0.2) | (0.2) | Interest expense, net |
| Reclassification before tax | (3.4) | 2.1 |  |
| Income tax expense (benefit) | 0.7 | (0.2) | Income tax provision |
| Reclassification net of tax | $(2.7) | $1.9 |  |
| Defined pension and postretirement benefit plans: |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of net actuarial losses | $2.3 | $2.3 | Other expense (income), net<sup>(2)</sup> |
| &nbsp;&nbsp;&nbsp;Amortization of prior service cost | 0.5 | 0.4 | Other expense (income), net<sup>(2)</sup> |
| Reclassification before tax | 2.8 | 2.7 |  |
| Income tax benefit | (0.7) | (0.7) | Income tax provision |
| Reclassification net of tax | $2.1 | $2.0 |  |
| &nbsp;&nbsp;&nbsp;Net losses (gains) reclassified from accumulated other comprehensive loss | $(0.6) | $3.9 |  |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Losses (Gains) included within the Condensed Consolidated Statements of Operations for the three months ended September 30, 2025 and 2024, respectively.

<sup>(2)</sup> &nbsp;&nbsp;&nbsp;&nbsp;These accumulated other comprehensive loss components are included in the computation of net periodic pension and postretirement benefit cost. Refer to Note 15 for additional information.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

---

| | | | |
|:---|:---|:---|:---|
| | **Amount Reclassified from Accumulated Other Comprehensive Loss** | **Amount Reclassified from Accumulated Other Comprehensive Loss** | **Affected Line Item within the Condensed Consolidated <br>Statements of Operations** |
|<br>**Details about Accumulated Other Comprehensive Loss Components** | **Nine Months Ended September 30, 2025**<sup>(1)</sup> | **Nine Months Ended September 30, 2024**<sup>(1)</sup> | **Affected Line Item within the Condensed Consolidated <br>Statements of Operations** |
| Derivatives: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net losses (gains) on foreign currency contracts | $(6.9) | $6.4 | Cost of goods sold |
| &nbsp;&nbsp;&nbsp;&nbsp;Net losses on commodity contracts |  | 0.3 | Cost of goods sold |
| &nbsp;&nbsp;&nbsp;&nbsp;Net gains on treasury rate locks | (0.6) | (0.5) | Interest expense, net |
| Reclassification before tax | (7.5) | 6.2 |  |
| Income tax expense (benefit) | 1.9 | (0.5) | Income tax provision |
| Reclassification net of tax | $(5.6) | $5.7 |  |
| Defined pension and postretirement benefit plans: |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of net actuarial losses | $6.6 | $6.7 | Other expense (income), net<sup>(2)</sup> |
| &nbsp;&nbsp;&nbsp;Amortization of prior service cost | 1.5 | 1.2 | Other expense (income), net<sup>(2)</sup> |
| Reclassification before tax | 8.1 | 7.9 |  |
| Income tax benefit | (2.1) | (2.3) | Income tax provision |
| Reclassification net of tax | $6.0 | $5.6 |  |
| &nbsp;&nbsp;&nbsp;Net losses reclassified from accumulated other comprehensive loss | $0.4 | $11.3 |  |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Losses (Gains) included within the Condensed Consolidated Statements of Operations for the nine months ended September 30, 2025 and 2024, respectively.

<sup>(2)</sup> &nbsp;&nbsp;&nbsp;&nbsp;These accumulated other comprehensive loss components are included in the computation of net periodic pension and postretirement benefit cost. Refer to Note 15 for additional information.

*Share Repurchase Program*

&nbsp;&nbsp;&nbsp;&nbsp;In November 2024, the Company entered into an accelerated share repurchase ("ASR") agreement with a financial institution to repurchase $22.0 million of shares of its common stock. The Company received approximately 228,969 shares associated with the completion of this transaction as of December 31, 2024. In November 2023, the Company entered into an ASR agreement with a financial institution to repurchase $53.0 million of shares of its common stock. The Company received approximately 371,669 shares associated with this transaction as of December 31, 2023. In January 2024, the Company received an additional 82,883 shares upon final settlement of its November 2023 ASR agreement. All shares received under the ASR agreement were retired upon receipt, and the excess of the purchase price over par value per share was recorded to a combination of "Additional paid-in capital" and "Retained earnings" within the Company's Condensed Consolidated Balance Sheets. During the three and nine months ended September 30, 2025, the Company did not purchase any shares directly or enter into any accelerated share repurchase agreements.

&nbsp;&nbsp;&nbsp;&nbsp;On July 9, 2025, the Company's Board of Directors authorized a new share repurchase program authorizing the Company to repurchase up to $1.0 billion of the Company's common stock, which has no expiration date. As of September 30, 2025, the remaining amount authorized to be repurchased under board-approved share repurchase authorizations was approximately $1,035.0 million, which has no expiration date.

*Dividends*

&nbsp;&nbsp;&nbsp;&nbsp;During the three months ended September 30, 2025 and 2024, the Company declared and paid cash dividends of $0.29 and $0.29 per common share, respectively. During the nine months ended September 30, 2025 and 2024, the Company declared

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

and paid cash dividends of $0.87 and $3.37 per common share, respectively. The Company paid a special variable dividend of $2.50 per common share during the second quarter of 2024. On October 23, 2025, the Company's Board of Directors declared a regular quarterly dividend of $0.29 per common share to be paid on December 15, 2025, to all stockholders of record as of the close of business on November 14, 2025.

**13.&nbsp;&nbsp;&nbsp;&nbsp;NET INCOME (LOSS) PER COMMON SHARE**

**&nbsp;&nbsp;&nbsp;&nbsp;**Basic net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during each period. Diluted net income (loss) per common share assumes the exercise of outstanding stock-settled stock appreciation rights ("SSARs") and the vesting of restricted stock unit awards ("RSUs") using the treasury stock method when there is no other circumstance other than the passage of time under which they would not be issued, and the effects of such assumptions are dilutive.

&nbsp;&nbsp;&nbsp;&nbsp;A reconciliation of net income (loss) attributable to AGCO Corporation and weighted average common shares outstanding for purposes of calculating basic and diluted net income (loss) per share for the three and nine months ended September 30, 2025 and 2024 is as follows (in millions, except per share data):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024**<sup>(1)</sup> |
| Basic net income (loss) per share: |  |  |  |  |
| &nbsp;&nbsp;Net income (loss) attributable to AGCO Corporation | $305.7 | $30.0 | $631.0 | $(169.1) |
| &nbsp;&nbsp;Weighted average number of common shares outstanding | 74.6 | 74.6 | 74.6 | 74.6 |
| Basic net income (loss) per share attributable to AGCO Corporation | $4.10 | $0.40 | $8.46 | $(2.27) |
| Diluted net income (loss) per share: |  |  |  |  |
| &nbsp;&nbsp;Net income (loss) attributable to AGCO Corporation | $305.7 | $30.0 | $631.0 | $(169.1) |
| &nbsp;&nbsp;&nbsp;Weighted average number of common shares outstanding | 74.6 | 74.6 | 74.6 | 74.6 |
| &nbsp;&nbsp;Dilutive SSARs and RSUs | 0.1 | 0.1 | 0.1 | 0.1 |
| &nbsp;&nbsp;&nbsp;Weighted average number of common shares and common share equivalents outstanding for purposes of computing diluted net income (loss) per share | 74.7 | 74.7 | 74.7 | 74.7 |
| Diluted net income (loss) per share attributable to AGCO Corporation | $4.09 | $0.40 | $8.45 | $(2.27) |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;As the Company has reported a loss for the nine months ended September 30, 2024, all potentially dilutive securities are antidilutive, and accordingly, basic net loss per share equals diluted net loss per share.

**14.&nbsp;&nbsp;&nbsp;&nbsp;INCOME TAXES**

&nbsp;&nbsp;&nbsp;&nbsp;The income tax provision (benefit) and effective tax rate for the three and nine months ended September 30, 2025 and 2024 are set forth below (in millions, except percentages):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| | $% | $% | $% | $% |
| Income tax provision (benefit) and effective tax rate | 14.2% | 41.6% | (35.1)% | (140.3)% |

---

&nbsp;&nbsp;&nbsp;&nbsp;Our effective tax rate varies from period to period due to the mix of taxable income and losses in the various tax jurisdictions in which we operate. During the three and nine months ended September 30, 2025, the Company's income tax provision included a net tax benefit of $4.7 million and $259.9 million, respectively, related to a legal entity reorganization. During the nine months ended September 30, 2024, the Brazilian courts confirmed a favorable tax ruling regarding the

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

taxability of certain state value added tax incentive benefits, which allowed the Company to record a $31.7 million reduction in the provision for income taxes.

&nbsp;&nbsp;&nbsp;&nbsp;The Company maintains a valuation allowance to reserve a portion of its net deferred tax assets in the United States and certain foreign jurisdictions. A valuation allowance is established when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company regularly assesses the likelihood that its deferred tax assets will be recovered from estimated future taxable income and available tax planning strategies and has determined that all adjustments to the valuation allowances have been deemed appropriate. In making this assessment, all available evidence was considered including the current economic climate, as well as reasonable tax planning strategies. The Company believes it is more likely than not that it will realize its remaining net deferred tax assets, net of the valuation allowance, in future years.

**15.&nbsp;&nbsp;&nbsp;&nbsp;PENSION AND POSTRETIREMENT BENEFIT PLANS**

&nbsp;&nbsp;&nbsp;&nbsp;Net periodic pension and postretirement benefit cost for the Company's defined pension and postretirement benefit plans for the three and nine months ended September 30, 2025 and 2024 are set forth below (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|<br>**Pension benefits** | **2025** | **2024** | **2025** | **2024** |
| Service cost | $2.0 | $2.0 | $5.7 | $6.2 |
| Interest cost | 7.0 | 7.0 | 20.3 | 20.9 |
| Expected return on plan assets | (6.7) | (7.7) | (19.5) | (23.1) |
| Amortization of net actuarial losses | 2.3 | 2.3 | 6.7 | 6.7 |
| Amortization of prior service cost | 0.4 | 0.4 | 1.2 | 1.1 |
| Net periodic pension cost | $5.0 | $4.0 | $14.4 | $11.8 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
|<br>**Postretirement benefits** | **2025** | **2024** | **2025** | **2024** |
| Service cost | $— | $— | $— | $0.1 |
| Interest cost | 0.4 | 0.4 | 1.1 | 1.2 |
| Amortization of net actuarial losses |  |  | (0.1) |  |
| Amortization of prior service cost | 0.1 |  | 0.3 | 0.1 |
| Net periodic postretirement benefit cost | $0.5 | $0.4 | $1.3 | $1.4 |

---

&nbsp;&nbsp;&nbsp;&nbsp;The components of net periodic pension and postretirement benefits cost, other than the service cost component, are included in "Other expense (income), net" in the Company's Condensed Consolidated Statements of Operations.

&nbsp;&nbsp;&nbsp;&nbsp;During the nine months ended September 30, 2025, the Company made approximately $11.9 million of contributions to its defined pension benefit plans. The Company currently estimates its minimum contributions for 2025 to its defined pension benefit plans will aggregate to approximately $15.4 million.

&nbsp;&nbsp;&nbsp;&nbsp;During the nine months ended September 30, 2025, the Company made approximately $1.3 million of contributions to its postretirement health care and life insurance benefit plans. The Company currently estimates that it will make approximately $1.7 million of contributions to its postretirement health care and life insurance benefit plans during 2025.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

**16.&nbsp;&nbsp;&nbsp;&nbsp;FAIR VALUE OF FINANCIAL INSTRUMENTS**

**&nbsp;&nbsp;&nbsp;&nbsp;**The Company categorizes its assets and liabilities into one of three levels based on the assumptions used in valuing the asset or liability. Estimates of fair value for financial assets and liabilities are based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Observable inputs (highest level) reflect market data obtained from independent sources, while unobservable inputs (lowest level) reflect internally developed market assumptions. In accordance with this guidance, fair value measurements are classified under the following hierarchy:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 - Quoted prices in active markets for identical assets or liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 - Quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and model-derived valuations in which all significant inputs are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 - Model-derived valuations in which one or more significant inputs are unobservable.

&nbsp;&nbsp;&nbsp;&nbsp;The Company categorizes its pension plan assets into one of the three levels of the fair value hierarchy, except for those measured using the net asset value per share (or its equivalent) practical expedient.

&nbsp;&nbsp;&nbsp;&nbsp;The Company enters into foreign currency, commodity and interest rate swap contracts. The fair values of the Company's derivative instruments are determined using discounted cash flow valuation models. The significant inputs used in these models are readily available in public markets, or can be derived from observable market transactions, and therefore have been classified as Level 2. Inputs used in these discounted cash flow valuation models for derivative instruments include the applicable exchange rates, forward rates or interest rates. Such models used for option contracts also use implied volatility. Refer to Note 11 for additional information on the Company's derivative instruments and hedging activities.

&nbsp;&nbsp;&nbsp;&nbsp;Assets and liabilities measured at fair value on a recurring basis as of September 30, 2025 and December 31, 2024 are summarized below (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** | **As of September 30, 2025** |
| | **Level 1** | **Level 2** | **Level 3** | **Total** |
| Derivative assets | $— | $4.5 | $— | $4.5 |
| Derivative liabilities |  | 50.9 |  | 50.9 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** | **As of December 31, 2024** |
| | **Level 1** | **Level 2** | **Level 3** | **Total** |
| Derivative assets | $— | $46.0 | $— | $46.0 |
| Derivative liabilities |  | 14.2 |  | 14.2 |

---

&nbsp;&nbsp;&nbsp;&nbsp;The carrying amounts of long-term debt under the Company's EIB Senior term loans due 2029 and 2030 and Senior term loans due between 2025 and 2028 approximate fair value based on the borrowing rates currently available to the Company for loans with similar terms and average maturities. At September 30, 2025, the estimated fair value of the Company's 0.800% Senior notes due 2028, based on listed market values, was approximately €563.7 million (or approximately $661.4 million), compared to the carrying value of €600.0 million (or approximately $704.0 million). At September 30, 2025, the estimated fair value of the Company's 5.450% senior notes due 2027, based on listed market values, was approximately $405.9 million, compared to the carrying value of $400.0 million. At September 30, 2025, the estimated fair value of the Company's 5.800% senior notes due 2034, based on listed market values, was approximately $728.1 million, compared to the carrying value of $700.0 million. Refer to Note 9 for additional information on the Company's long-term debt.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

**17.&nbsp;&nbsp;&nbsp;&nbsp;COMMITMENTS AND CONTINGENCIES**

***Leases***

&nbsp;&nbsp;&nbsp;&nbsp;Lease payment amounts for operating and finance leases with remaining terms greater than one year as of September 30, 2025 and December 31, 2024 were as follows (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **September 30, 2025** | **September 30, 2025** | **December 31, 2024** | **December 31, 2024** |
| | **Operating Leases**<sup>(1)</sup> | **Finance Leases** | **Operating Leases**<sup>(1)</sup> | **Finance Leases** |
| 2025 | $14.7 | $0.2 | $53.3 | $0.7 |
| 2026 | 52.8 | 0.5 | 43.9 | 0.5 |
| 2027 | 37.8 | 0.4 | 29.7 | 0.4 |
| 2028 | 29.6 | 0.3 | 22.6 | 0.3 |
| 2029 | 21.2 | 0.3 | 15.2 | 0.2 |
| Thereafter | 46.0 | 6.2 | 42.2 | 5.5 |
| Total lease payments | 202.1 | 7.9 | 206.9 | 7.6 |
| &nbsp;&nbsp;Less: imputed interest<sup>(2)</sup> | (30.3) | (2.0) | (34.4) | (2.0) |
| Present value of leased liabilities | $171.8 | $5.9 | $172.5 | $5.6 |

---

__________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Operating lease payments include options to extend or terminate at the Company's sole discretion, which are included in the determination of lease term when they are reasonably certain to be exercised.

<sup>(2)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Calculated for each lease using either the implicit interest rate or the incremental borrowing rate, when the implicit interest rate is not readily available.

***Off-Balance Sheet Arrangements***

*Guarantees*

&nbsp;&nbsp;&nbsp;&nbsp;At September 30, 2025, the Company had outstanding guarantees issued to its Argentine finance joint venture, AGCO Capital Argentina S.A. ("AGCO Capital"), of approximately $70.3 million. Such guarantees generally obligate the Company to repay outstanding finance obligations owed to AGCO Capital if end users default on such loans to the extent that, due to non-credit risk, the end users are not able, or not required, to pay their loans, or are required to pay in a different currency than the one agreed in their loan. The Company also has obligations to guarantee indebtedness owed to certain of its finance joint ventures if dealers or end users default on loans. Losses under such guarantees historically have been insignificant. The Company believes the credit risk associated with these guarantees is not material.

&nbsp;&nbsp;&nbsp;&nbsp;In addition, at September 30, 2025, the Company had accrued approximately $13.3 million of outstanding guarantees of residual values that may be owed to its finance joint ventures in the United States and Canada due upon expiration of certain eligible operating leases between the finance joint ventures and end users. The maximum potential amount of future payments under these guarantees is approximately $214.3 million.

*Other*

&nbsp;&nbsp;&nbsp;&nbsp;The Company sells a majority of its wholesale receivables in North America, Europe and Brazil to its U.S., Canadian, European and Brazilian finance joint ventures. The Company also sells certain accounts receivable under factoring arrangements to financial institutions around the world. The Company accounts for the sale of such receivables as off-balance sheet transactions. Refer to Note 4 for discussion of the Company's accounts receivable sales agreements.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

*Contingencies*

&nbsp;&nbsp;&nbsp;&nbsp;The Company is a party to various other legal claims and actions incidental to its business. The Company believes that none of these claims or actions, either individually or in the aggregate, are material to its business or financial statements as a whole, including its results of operations and financial condition.

**18.&nbsp;&nbsp;&nbsp;&nbsp;REVENUE**

***Contract Liabilities***

&nbsp;&nbsp;&nbsp;&nbsp;Contract liabilities relate to the following: (1) unrecognized revenues where payment of consideration precedes the Company's performance with respect to extended warranty and maintenance contracts and where the performance obligation is satisfied over time, (2) unrecognized revenues where payment of consideration precedes the Company's performance with respect to precision agriculture technology services and where the performance obligation is satisfied over time and (3) unrecognized revenues where payment of consideration precedes the Company's performance with respect to certain grain storage and protein production systems and where the performance obligation is satisfied over time. The Company divested the majority of its Grain & Protein ("G&P") business on November 1, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;Significant changes in the balance of contract liabilities for the three and nine months ended September 30, 2025 and 2024 were as follows (in millions):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| | **2025** | **2024** |
| Balance at beginning of period | $377.7 | $331.7 |
| Advance consideration received | 49.3 | 50.4 |
| Revenue recognized during the period for extended warranty contracts, maintenance services and technology services | (47.5) | (40.0) |
| Revenue recognized during the period related to grain storage and protein production systems | (0.1) | (4.0) |
| Reclassified to held for sale<sup>(1)</sup> |  | (0.4) |
| Foreign currency translation | (0.5) | 8.9 |
| Balance at September 30 | $378.9 | $346.6 |

---

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** |
| Balance at beginning of period | $341.5 | $310.7 |
| Acquisitions |  | 21.0 |
| Advance consideration received | 154.8 | 156.4 |
| Revenue recognized during the period for extended warranty contracts, maintenance services and technology services | (142.3) | (117.2) |
| Revenue recognized during the period related to grain storage and protein production systems | (1.0) | (16.2) |
| Reclassified to held for sale<sup>(1)</sup> |  | (10.9) |
| Foreign currency translation | 25.9 | 2.8 |
| Balance at September 30 | $378.9 | $346.6 |

---

__________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Reclassification resulting from the Company's classification of the majority of the G&P business as held for sale as of June 30, 2024. The Company divested the majority of its G&P business on November 1, 2024. Refer to Note 3 for additional information.

&nbsp;&nbsp;&nbsp;&nbsp;The contract liabilities are classified as either "Accrued expenses" or "Other current liabilities" and "Other noncurrent liabilities" in the Company's Condensed Consolidated Balance Sheets. During the three and nine months ended September 30, 2025, the Company recognized approximately $38.0 million and $124.5 million of revenue that was recorded as a contract

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

liability at the beginning of 2025. During the three and nine months ended September 30, 2024, the Company recognized approximately $35.7 million and $106.9 million of revenue that was recorded as a contract liability at the beginning of 2024.

***Remaining Performance Obligations***

&nbsp;&nbsp;&nbsp;&nbsp;The estimated revenues expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) as of September 30, 2025 are $44.4 million for the remainder of 2025, $144.4 million in 2026, $100.7 million in 2027, $51.6 million in 2028 and $29.7 million thereafter, and relate primarily to extended warranty contracts. The Company applied the practical expedient in ASU 2014-09 and has not disclosed information about remaining performance obligations that have original expected durations of 12 months or less.

***Disaggregated Revenue***

&nbsp;&nbsp;&nbsp;&nbsp;Net sales for the three months ended September 30, 2025 disaggregated by primary geographical markets and major products consisted of the following (in millions):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **North America** | **South America** | **Europe/Middle East** | **Asia/Pacific/Africa** | **Consolidated** |
| Primary geographical markets: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;United States | $289.2 | $— | $— | $— | $289.2 |
| &nbsp;&nbsp;&nbsp;Canada | 70.7 |  |  |  | 70.7 |
| &nbsp;&nbsp;&nbsp;Brazil |  | 241.9 |  |  | 241.9 |
| &nbsp;&nbsp;&nbsp;Other South America |  | 77.2 |  |  | 77.2 |
| &nbsp;&nbsp;&nbsp;Germany |  |  | 408.1 |  | 408.1 |
| &nbsp;&nbsp;&nbsp;France |  |  | 304.4 |  | 304.4 |
| &nbsp;&nbsp;&nbsp;United Kingdom and Ireland |  |  | 140.6 |  | 140.6 |
| &nbsp;&nbsp;&nbsp;Finland and Scandinavia |  |  | 166.9 |  | 166.9 |
| &nbsp;&nbsp;&nbsp;Italy |  |  | 119.6 |  | 119.6 |
| &nbsp;&nbsp;&nbsp;Other Europe |  |  | 421.7 |  | 421.7 |
| &nbsp;&nbsp;&nbsp;Middle East and Algeria |  |  | 52.5 |  | 52.5 |
| &nbsp;&nbsp;&nbsp;Africa |  |  |  | 31.3 | 31.3 |
| &nbsp;&nbsp;&nbsp;Asia |  |  |  | 31.6 | 31.6 |
| &nbsp;&nbsp;&nbsp;Australia and New Zealand |  |  |  | 94.2 | 94.2 |
| &nbsp;&nbsp;&nbsp;Mexico, Central America and Caribbean | 23.1 | 3.3 |  |  | 26.4 |
|  | $383.0 | $322.4 | $1613.8 | $157.1 | $2476.3 |
| Major products: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Tractors | $159.9 | $217.7 | $1174.7 | $98.3 | $1650.6 |
| &nbsp;&nbsp;&nbsp;Replacement parts | 100.8 | 37.3 | 332.1 | 28.3 | 498.5 |
| &nbsp;&nbsp;&nbsp;Grain storage and protein production systems |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Combines, application equipment and other machinery | 122.3 | 67.4 | 107.0 | 30.5 | 327.2 |
|  | $383.0 | $322.4 | $1613.8 | $157.1 | $2476.3 |

---

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

&nbsp;&nbsp;&nbsp;&nbsp;Net sales for the three months ended September 30, 2024 disaggregated by primary geographical markets and major products consisted of the following (in millions):

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **North America**<sup>(1)</sup> | **South America** | **Europe/Middle East**<sup>(1)</sup> | **Asia/Pacific/Africa**<sup>(1)</sup> | **Total Segments** | **Other**<sup>(2)</sup> | **Consolidated** |
| Primary geographical markets: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;United States | $435.7 | $— | $— | $— | $435.7 | $145.0 | $580.7 |
| &nbsp;&nbsp;&nbsp;Canada | 102.8 |  |  |  | 102.8 | 20.4 | 123.2 |
| &nbsp;&nbsp;&nbsp;Brazil |  | 250.0 |  |  | 250.0 | 20.6 | 270.6 |
| &nbsp;&nbsp;&nbsp;Other South America |  | 98.0 |  |  | 98.0 | 8.7 | 106.7 |
| &nbsp;&nbsp;&nbsp;Germany |  |  | 292.6 |  | 292.6 | 1.9 | 294.5 |
| &nbsp;&nbsp;&nbsp;France |  |  | 256.1 |  | 256.1 | 1.3 | 257.4 |
| &nbsp;&nbsp;&nbsp;United Kingdom and Ireland |  |  | 124.3 |  | 124.3 | 2.2 | 126.5 |
| &nbsp;&nbsp;&nbsp;Finland and Scandinavia |  |  | 165.9 |  | 165.9 | 2.2 | 168.1 |
| &nbsp;&nbsp;&nbsp;Italy |  |  | 67.5 |  | 67.5 | 6.8 | 74.3 |
| &nbsp;&nbsp;&nbsp;Other Europe |  |  | 299.7 |  | 299.7 | 15.7 | 315.4 |
| &nbsp;&nbsp;&nbsp;Middle East and Algeria |  |  | 59.8 |  | 59.8 | 2.1 | 61.9 |
| &nbsp;&nbsp;&nbsp;Africa |  |  |  | 25.6 | 25.6 | 3.3 | 28.9 |
| &nbsp;&nbsp;&nbsp;Asia |  |  |  | 52.9 | 52.9 | 11.9 | 64.8 |
| &nbsp;&nbsp;&nbsp;Australia and New Zealand |  |  |  | 88.4 | 88.4 | 1.3 | 89.7 |
| &nbsp;&nbsp;&nbsp;Mexico, Central America and Caribbean | 26.0 | 2.8 |  |  | 28.8 | 7.8 | 36.6 |
|  | $564.4 | $350.8 | $1266.0 | $166.9 | $2348.1 | $251.2 | $2599.3 |
| Major products: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Tractors | $238.4 | $224.0 | $842.8 | $99.3 | $1404.5 | $— | $1404.5 |
| &nbsp;&nbsp;&nbsp;Replacement parts | 109.6 | 40.6 | 311.1 | 27.0 | 488.3 |  | 488.3 |
| &nbsp;&nbsp;&nbsp;Grain storage and protein production systems |  |  |  | 4.3 | 4.3 | 251.2 | 255.5 |
| &nbsp;&nbsp;&nbsp;Combines, application equipment and other machinery | 216.4 | 86.2 | 112.0 | 36.4 | 451.0 |  | 451.0 |
|  | $564.4 | $350.8 | $1266.0 | $166.9 | $2348.1 | $251.2 | $2599.3 |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Rounding may impact summation of amounts.

<sup>(2)</sup> &nbsp;&nbsp;&nbsp;&nbsp;"Other" represents the results for the three months ended September 30, 2024 for the majority of the Company's G&P business which was divested on November 1, 2024. The results of the G&P business through the date of the divestiture were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

&nbsp;&nbsp;&nbsp;&nbsp;Net sales for the nine months ended September 30, 2025 disaggregated by primary geographical markets and major products consisted of the following (in millions):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **North America** | **South America** | **Europe/Middle East** | **Asia/Pacific/Africa** | **Consolidated** |
| Primary geographical markets: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;United States | $884.5 | $— | $— | $— | $884.5 |
| &nbsp;&nbsp;&nbsp;Canada | 238.8 |  |  |  | 238.8 |
| &nbsp;&nbsp;&nbsp;Brazil |  | 634.0 |  |  | 634.0 |
| &nbsp;&nbsp;&nbsp;Other South America |  | 213.7 |  |  | 213.7 |
| &nbsp;&nbsp;&nbsp;Germany |  |  | 1167.6 |  | 1167.6 |
| &nbsp;&nbsp;&nbsp;France |  |  | 891.6 |  | 891.6 |
| &nbsp;&nbsp;&nbsp;United Kingdom and Ireland |  |  | 392.8 |  | 392.8 |
| &nbsp;&nbsp;&nbsp;Finland and Scandinavia |  |  | 550.0 |  | 550.0 |
| &nbsp;&nbsp;&nbsp;Italy |  |  | 293.8 |  | 293.8 |
| &nbsp;&nbsp;&nbsp;Other Europe |  |  | 1209.6 |  | 1209.6 |
| &nbsp;&nbsp;&nbsp;Middle East and Algeria |  |  | 213.8 |  | 213.8 |
| &nbsp;&nbsp;&nbsp;Africa |  |  |  | 76.0 | 76.0 |
| &nbsp;&nbsp;&nbsp;Asia |  |  |  | 115.3 | 115.3 |
| &nbsp;&nbsp;&nbsp;Australia and New Zealand |  |  |  | 196.1 | 196.1 |
| &nbsp;&nbsp;&nbsp;Mexico, Central America and Caribbean | 76.2 | 8.0 |  |  | 84.2 |
|  | $1199.5 | $855.7 | $4719.2 | $387.4 | $7161.8 |
| Major products: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Tractors | $454.6 | $561.9 | $3344.2 | $242.2 | $4602.9 |
| &nbsp;&nbsp;&nbsp;Replacement parts | 300.3 | 113.7 | 944.3 | 75.2 | 1433.5 |
| &nbsp;&nbsp;&nbsp;Grain storage and protein production systems |  |  |  | 1.1 | 1.1 |
| &nbsp;&nbsp;&nbsp;Combines, application equipment and other machinery | 444.6 | 180.1 | 430.7 | 68.9 | 1124.3 |
|  | $1199.5 | $855.7 | $4719.2 | $387.4 | $7161.8 |

---

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

&nbsp;&nbsp;&nbsp;&nbsp;Net sales for the nine months ended September 30, 2024 disaggregated by primary geographical markets and major products consisted of the following (in millions):

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **North America** | **South America** | **Europe/Middle East** | **Asia/Pacific/Africa** | **Total Segments** | **Other**<sup>(1)</sup> | **Consolidated** |
| Primary geographical markets: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;United States | $1389.2 | $— | $— | $— | $1389.2 | $439.5 | $1828.7 |
| &nbsp;&nbsp;&nbsp;Canada | 318.2 |  |  |  | 318.2 | 56.8 | 375.0 |
| &nbsp;&nbsp;&nbsp;Brazil |  | 683.6 |  |  | 683.6 | 72.8 | 756.4 |
| &nbsp;&nbsp;&nbsp;Other South America |  | 248.5 |  |  | 248.5 | 18.0 | 266.5 |
| &nbsp;&nbsp;&nbsp;Germany |  |  | 1344.9 |  | 1344.9 | 10.2 | 1355.1 |
| &nbsp;&nbsp;&nbsp;France |  |  | 970.5 |  | 970.5 | 5.1 | 975.6 |
| &nbsp;&nbsp;&nbsp;United Kingdom and Ireland |  |  | 390.6 |  | 390.6 | 4.6 | 395.2 |
| &nbsp;&nbsp;&nbsp;Finland and Scandinavia |  |  | 526.2 |  | 526.2 | 6.7 | 532.9 |
| &nbsp;&nbsp;&nbsp;Italy |  |  | 227.1 |  | 227.1 | 19.3 | 246.4 |
| &nbsp;&nbsp;&nbsp;Other Europe |  |  | 1051.9 |  | 1051.9 | 37.9 | 1089.8 |
| &nbsp;&nbsp;&nbsp;Middle East and Algeria |  |  | 331.2 |  | 331.2 | 3.9 | 335.1 |
| &nbsp;&nbsp;&nbsp;Africa |  |  |  | 65.1 | 65.1 | 9.9 | 75.0 |
| &nbsp;&nbsp;&nbsp;Asia |  |  |  | 166.2 | 166.2 | 35.5 | 201.7 |
| &nbsp;&nbsp;&nbsp;Australia and New Zealand |  |  |  | 226.7 | 226.7 | 3.7 | 230.4 |
| &nbsp;&nbsp;&nbsp;Mexico, Central America and Caribbean | 85.3 | 7.6 |  |  | 92.9 | 17.9 | 110.8 |
|  | $1792.7 | $939.7 | $4842.4 | $458.0 | $8032.8 | $741.8 | $8774.6 |
| Major products: |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Tractors | $718.0 | $604.1 | $3468.5 | $274.0 | $5064.6 | $— | $5064.6 |
| &nbsp;&nbsp;&nbsp;Replacement parts | 321.3 | 119.3 | 896.0 | 73.4 | 1410.0 |  | 1410.0 |
| &nbsp;&nbsp;&nbsp;Grain storage and protein production systems |  |  |  | 15.0 | 15.0 | 741.8 | 756.8 |
| &nbsp;&nbsp;&nbsp;Combines, application equipment and other machinery | 753.4 | 216.3 | 477.9 | 95.6 | 1543.2 |  | 1543.2 |
|  | $1792.7 | $939.7 | $4842.4 | $458.0 | $8032.8 | $741.8 | $8774.6 |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;"Other" represents the results for the nine months ended September 30, 2024 for the majority of the Company's G&P business which was divested on November 1, 2024. The results of the G&P business through the date of the divestiture were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

**19.&nbsp;&nbsp;&nbsp;&nbsp;SEGMENT REPORTING**

&nbsp;&nbsp;&nbsp;&nbsp;The Company has four operating segments which are also its reportable segments which consist of the North America, South America, Europe/Middle East and Asia/Pacific/Africa regions. The Company's reportable segments are geography based and distribute a full range of agricultural machinery and precision agriculture technology. The Company's Chief Operating Decision Maker ("CODM"), Eric P. Hansotia, Chairman of the Board, President and Chief Executive Officer, evaluates segment performance primarily based on income from operations. The CODM utilizes income from operations to evaluate each segment's performance including the allocation of resources. Sales for each segment are based on the location of the third-party customer. The Company's selling, general and administrative expenses and engineering expenses are generally charged to each segment based on the region and division where the expenses are incurred. As a result, the components of income (loss) from operations for one segment may not be comparable to another segment. Segment results for the three and nine months ended September 30, 2025 and 2024 and assets as of September 30, 2025 and December 31, 2024 based on the Company's reportable segments are as follows (in millions):

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Three Months Ended**<br>**September 30,** | **North America** | **South America** | **Europe/Middle East** | **Asia/Pacific/Africa** | **Total Segments** | **Other**<sup>(1)</sup> | **Total** |
| **2025** |  |  |  |  |  |  |  |
| Net sales | $383.0 | $322.4 | $1613.8 | $157.1 | $2476.3 | $— | $2476.3 |
| Cost of goods sold | 302.5 | 259.1 | 1143.9 | 124.3 | 1829.8 |  | 1829.8 |
| Selling, general and administrative expenses | 84.6 | 32.7 | 146.0 | 21.7 | 285.0 |  | 285.0 |
| Engineering expenses | 36.0 | 12.1 | 71.5 | 3.4 | 123.0 |  | 123.0 |
| Income (loss) from operations | $(40.1) | $18.5 | $252.4 | $7.7 | $238.5 | $— | $238.5 |
| Depreciation | $14.8 | $8.5 | $36.4 | $3.0 | $62.7 | $— | $62.7 |
| Capital expenditures | 9.9 | 9.1 | 49.5 | 0.4 | 68.9 |  | 68.9 |
| **2024** |  |  |  |  |  |  |  |
| Net sales<sup>(2)</sup> | $564.4 | $350.8 | $1266.0 | $166.9 | $2348.1 | $251.2 | $2599.3 |
| Cost of goods sold | 426.1 | 272.1 | 974.1 | 135.1 | 1807.4 | 188.8 | 1996.2 |
| Selling, general and administrative expenses | 90.7 | 24.7 | 134.9 | 21.8 | 272.1 | 21.9 | 294.0 |
| Engineering expenses | 31.3 | 12.9 | 67.7 | 3.2 | 115.1 | 6.2 | 121.3 |
| Income from operations<sup>(3)</sup> | $16.3 | $41.1 | $89.3 | $6.8 | $153.5 | $34.3 | $187.8 |
| Depreciation | $15.6 | $8.5 | $33.2 | $3.6 | $60.9 | $— | $60.9 |
| Capital expenditures | 9.0 | 9.1 | 64.7 | 0.9 | 83.7 | 2.6 | 86.3 |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;"Other" represents the results for the three months ended September 30, 2024 for the majority of the Company's Grain & Protein ("G&P") business which was divested on November 1, 2024. The results of the G&P business through the date of the divestiture were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments.

<sup>(2)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Of the $251.2 million of the net sales of the divested G&P business recast to "Other", $171.7 million, $30.8 million, $32.2 million and $16.5 million were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments, respectively.

<sup>(3)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Of the $34.3 million of the income (loss) from operations of the divested G&P business recast to "Other", $36.4 million, $4.0 million, $(6.3) million and $0.2 million were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments, respectively.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Nine Months Ended**<br>**September 30,** | **North America** | **South America** | **Europe/Middle East** | **Asia/Pacific/Africa** | **Total Segments** | **Other**<sup>(1)</sup> | **Total** |
| **2025** |  |  |  |  |  |  |  |
| Net sales | $1199.5 | $855.7 | $4719.2 | $387.4 | $7161.8 | $— | $7161.8 |
| Cost of goods sold | 925.4 | 688.1 | 3414.0 | 308.6 | 5336.1 |  | 5336.1 |
| Selling, general and administrative expenses | 251.8 | 94.8 | 421.3 | 56.1 | 824.0 |  | 824.0 |
| Engineering expenses | 104.3 | 28.4 | 215.8 | 8.3 | 356.8 |  | 356.8 |
| Income (loss) from operations | $(82.0) | $44.4 | $668.1 | $14.4 | $644.9 | $— | $644.9 |
| Depreciation | $44.0 | $24.5 | $110.4 | $8.4 | $187.3 | $— | $187.3 |
| Capital expenditures | 26.5 | 19.7 | 111.1 | 2.0 | 159.3 |  | 159.3 |
| **2024** |  |  |  |  |  |  |  |
| Net sales<sup>(2)</sup> | $1792.7 | $939.7 | $4842.4 | $458.0 | $8032.8 | $741.8 | $8774.6 |
| Cost of goods sold | 1353.2 | 761.7 | 3524.5 | 363.4 | 6002.8 | 561.4 | 6564.2 |
| Selling, general and administrative expenses | 256.8 | 78.5 | 418.0 | 59.5 | 812.8 | 80.1 | 892.9 |
| Engineering expenses | 101.8 | 40.0 | 219.9 | 8.8 | 370.5 | 19.5 | 390.0 |
| Income from operations<sup>(3)</sup> | $80.9 | $59.5 | $680.0 | $26.3 | $846.7 | $80.8 | $927.5 |
| Depreciation | $45.5 | $26.5 | $98.3 | $12.2 | $182.5 | $6.9 | $189.4 |
| Capital expenditures | 42.3 | 32.2 | 195.8 | 2.8 | 273.1 | 6.2 | 279.3 |
| **Assets** |  |  |  |  |  |  |  |
| As of September 30, 2025 | $1546.7 | $1099.1 | $3126.9 | $697.3 | $6470.0 | $— | $6470.0 |
| As of December 31, 2024 | 1527.9 | 946.9 | 2841.4 | 697.7 | 6013.9 |  | 6013.9 |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;"Other" represents the results for the nine months ended September 30, 2024 for the majority of the Company's G&P business which was divested on November 1, 2024. The results of the G&P business through the date of the divestiture were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments.

<sup>(2)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Of the $741.8 million of the net sales of the divested G&P business recast to "Other", $510.8 million, $94.2 million, $87.7 million and $49.1 million were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments, respectively.

<sup>(3)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Of the $80.8 million of the income (loss) from operations of the divested G&P business recast to "Other", $90.9 million, $14.4 million, $(25.6) million and $1.1 million were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments, respectively.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

&nbsp;&nbsp;&nbsp;&nbsp;A reconciliation from the segment information to the consolidated balances for income from operations is set forth below (in millions):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Nine Months Ended<br>September 30,** | **Nine Months Ended<br>September 30,** |
| | **2025** | **2024** | **2025** | **2024** |
| Segment income from operations | $238.5 | $153.5 | $644.9 | $846.7 |
| Other<sup>(1)</sup> |  | 34.3 |  | 80.8 |
| Impairment charges | 0.6 | (0.2) | (7.3) | (5.3) |
| Loss on sale of business |  | (3.2) | (12.3) | (497.8) |
| Corporate expenses | (48.9) | (45.3) | (144.7) | (161.2) |
| Amortization of intangibles | (23.0) | (8.8) | (54.0) | (54.4) |
| Stock compensation expense | (6.9) | (5.0) | (24.3) | (20.4) |
| Restructuring and business optimization expenses | (8.7) | (10.5) | (37.3) | (41.7) |
| Consolidated income from operations | $151.6 | $114.8 | $365.0 | $146.7 |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;"Other" represents the results for the three and nine months ended September 30, 2024 for the majority of the Company's G&P business which was divested on November 1, 2024. The results of the G&P business through the date of the divestiture were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments.

**20.&nbsp;&nbsp;&nbsp;&nbsp;RELATED PARTY TRANSACTIONS**

**&nbsp;&nbsp;&nbsp;&nbsp;**As of June 30, 2025 the Company entered into several agreements with Tractors and Farm Equipment Limited ("TAFE"), including the ones described further below among others, to resolve all outstanding disputes and other matters related to the commercial relationship between AGCO and TAFE as well as TAFE's shareholding in AGCO, ownership and use of the Massey Ferguson brand in India and certain other countries, and other key governance issues between the parties. Specifically as it relates to AGCO's shareholding in TAFE, the Company and TAFE entered into a Buyback Agreement (the "Buyback Agreement") pursuant to which TAFE will repurchase the Company's remaining shareholdings in TAFE for an aggregate amount of $260 million. On September 30, 2025, AGCO completed the sale to TAFE of AGCO's ownership interest in TAFE for an aggregate amount of $260 million, with after-tax proceeds from the sale totaling approximately $230 million and recorded a gain of $251.9 million on the sale of the investment in affiliate within "Other expense (income), net" in the Company's Condensed Consolidated Statements of Operations. As part of the sale process, the substantive provisions of the agreements AGCO entered into with TAFE on June 30, 2025 became effective, and the Amended and Restated Letter Agreement between AGCO and TAFE dated April 24, 2019, as most recently amended on July 7, 2025, expired.

*Settlement Agreements*

**&nbsp;&nbsp;&nbsp;&nbsp;**On June 30, 2025, the Company and TAFE entered into an Arbitrations Settlement Agreement and an India Litigation Settlement Agreement (collectively, the "Settlement Agreements") pursuant to which the parties agreed to resolve claims arising from the Company's termination of various commercial and brand agreements with TAFE and related arbitrations and litigation. Under the Settlement Agreements, the parties agreed to mutually release any and all claims against one another.

*Intellectual Property Agreement*

**&nbsp;&nbsp;&nbsp;&nbsp;**On June 30, 2025, the Company and TAFE entered into an Intellectual Property Agreement (the "Intellectual Property Agreement") pursuant to which TAFE will take ownership of the Massey Ferguson brand in India, Nepal and Bhutan, having previously been a brand licensee for over 60 years, and the Company will retain certain protective rights, including rights of first refusal upon a proposed transfer of these intellectual property assets. The Intellectual Property Agreement also provides for certain customary confidentiality provisions.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Notes to Condensed Consolidated Financial Statements - Continued**

**(unaudited)**

*Buyback Agreement*

**&nbsp;&nbsp;&nbsp;&nbsp;**On June 30, 2025, the Company and TAFE entered into a Buyback Agreement (the "Buyback Agreement") pursuant to which TAFE will repurchase the Company's remaining shareholdings in TAFE for an aggregate amount of $260 million. As discussed above, AGCO completed the sale to TAFE of AGCO's ownership interest in TAFE on September 30, 2025.

*Cooperation Agreement*

**&nbsp;&nbsp;&nbsp;&nbsp;**On June 30, 2025, the Company and TAFE entered into a Cooperation Agreement (the "Cooperation Agreement") pursuant to which TAFE agreed to standstill provisions with respect to its actions with regard to the Company, including the limitation on TAFE purchasing additional shares of the Company that would increase its holdings above its current percentage of outstanding shares, the requirement to vote its shares of the Company in accordance with recommendations from the Company's Board of Directors and not engaging in future public stockholder activism. The standstill provisions do not expire. TAFE retained the discretion to vote independently on any publicly-announced proposals related to an Extraordinary Transaction (as defined in the Cooperation Agreement). The Cooperation Agreement releases TAFE from the restriction on purchasing shares in the Company following certain events such as (i) the Company's public announcement of a possible sale of the Company, (ii) any person commencing a Board-approved public tender to acquire the Company, (iii) certain persons (other than TAFE) acquiring 12.5% or more of the Company's outstanding shares, (iv) any person commencing a Qualified Tender Offer (as defined in the Cooperation Agreement), (v) any person commencing a public tender offer by filing a Schedule TO, or (vi) any person publicly announcing its intention to commence a public tender offer or makes a public offer. TAFE also agreed to participate pro rata in the Company's share repurchase programs as authorized by the Company's Board of Directors from time to time, but retains the right to maintain its current percentage level of beneficial ownership of the Company's Common Stock.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**ITEM 2.&nbsp;&nbsp;&nbsp;&nbsp;MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS**

**GENERAL**

&nbsp;&nbsp;&nbsp;&nbsp;Our operations are subject to the cyclical and seasonal nature of the agricultural industry. Sales of our equipment are affected by, among other things, changes in farm income, farm land values and debt levels, financing costs, acreage planted, crop yields, weather conditions, the demand for agricultural commodities, commodity and protein prices, agricultural product demand and general economic conditions and government policies, tariffs and subsidies. We sell our equipment, precision agriculture technology and replacement parts to our independent dealers, distributors and other customers. A large majority of our sales are to independent dealers and distributors that sell our products to end users. To the extent practicable, we attempt to sell products to our dealers and distributors on a level basis throughout the year to reduce the effect of seasonal demands on our manufacturing operations and to minimize our investment in inventories. However, retail sales by dealers to farmers are highly seasonal and are a function of the timing of the planting and harvesting seasons. In certain markets, particularly in North America, there is often a time lag, which varies based on the timing and level of retail demand, between our sale of the equipment to the dealer and the dealer's sale to a retail customer.

&nbsp;&nbsp;&nbsp;&nbsp;The recent announcements of significant trade policy and tariff actions by the U.S. government, including but not limited to tariffs on imported steel and aluminum products, tariffs on certain imports from China, tariffs on certain imports from Canada and Mexico, announced trade deal between the United States and European Union of baseline tariffs on certain imports from the European Union, and baseline tariffs on most imports from most other countries, continue to create significant uncertainty and potential risks for our business. These announcements in some cases were followed by delays and changes in implementation, and the ultimate tariff structures are unclear at the current time. Depending on the countries affected, increases in tariffs have raised the costs of inputs used in manufacturing our products, which in turn has impacted our cost of goods sold. Additionally, higher tariffs may lead to increased after-tariff sales prices for the products we sell. The impacts of the tariffs may be partially mitigated as a majority of our sales and manufacturing takes place outside the United States. While we are actively exploring opportunities to mitigate these increased costs, there can be no guarantee that we will be able to fully offset the impact of these tariffs. Furthermore, the imposition of retaliatory tariffs from other countries on our exported products could negatively affect our sales and marketplace access in those countries. Moreover, the uncertainty of the tariff changes and any future trade policy changes has adversely impacted, and is expected to continue to adversely impact, our sales.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

**(continued)**

**RESULTS OF OPERATIONS**

**Financial Highlights**

&nbsp;&nbsp;&nbsp;&nbsp;The following tables set forth the percentage relationship to net sales of certain items included in our Condensed Consolidated Statements of Operations (in millions, except percentages):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** |
| | **2025** | **2024** |
| | $**% of Net Sales**<sup>(1)</sup> | $**% of Net Sales**<sup>(1)</sup> |
| Net sales | 100.0% | 100.0% |
| Cost of goods sold | 73.9 | 76.8 |
| Gross profit | 26.1 | 23.2 |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 13.8 | 13.2 |
| &nbsp;&nbsp;&nbsp;Engineering expenses | 5.0 | 4.7 |
| &nbsp;&nbsp;&nbsp;Amortization of intangibles | 0.9 | 0.3 |
| &nbsp;&nbsp;&nbsp;Impairment charges |  |  |
| &nbsp;&nbsp;Restructuring and business optimization expenses | 0.4 | 0.4 |
| &nbsp;&nbsp;Loss on sale of business |  | 0.1 |
| Income from operations | 6.1 | 4.4 |
| &nbsp;&nbsp;&nbsp;Interest expense, net | 0.6 | 1.3 |
| &nbsp;&nbsp;Other expense (income), net | (8.4) | 2.0 |
| Income before income taxes and equity in net earnings of affiliates | 13.9 | 1.1 |
| &nbsp;&nbsp;Income tax provision | 2.0 | 0.5 |
| Income before equity in net earnings of affiliates | 11.9 | 0.6 |
| &nbsp;&nbsp;&nbsp;Equity in net earnings of affiliates | 0.3 | 0.5 |
| Net income | 12.2 | 1.1 |
| Net loss attributable to noncontrolling interests | 0.1 |  |
| Net income attributable to AGCO Corporation | 12.3% | 1.2% |

---

___________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Rounding may impact summation of amounts.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

**(continued)**

---

| | | |
|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** |
| | **2025** | **2024** |
| | $**% of Net Sales**<sup>(1)</sup> | $**% of Net Sales**<sup>(1)</sup> |
| Net sales | 100.0% | 100.0% |
| Cost of goods sold | 74.5 | 74.8 |
| Gross profit | 25.5 | 25.2 |
| &nbsp;&nbsp;&nbsp;Selling, general and administrative expenses | 13.9 | 12.2 |
| &nbsp;&nbsp;&nbsp;Engineering expenses | 5.0 | 4.4 |
| &nbsp;&nbsp;&nbsp;Amortization of intangibles | 0.8 | 0.6 |
| &nbsp;&nbsp;&nbsp;Impairment charges | 0.1 | 0.1 |
| &nbsp;&nbsp;&nbsp;Restructuring and business optimization expenses | 0.5 | 0.5 |
| &nbsp;&nbsp;Loss on sale of business | 0.2 | 5.7 |
| Income from operations | 5.1 | 1.7 |
| &nbsp;&nbsp;&nbsp;Interest expense, net | 0.7 | 0.7 |
| &nbsp;&nbsp;Other expense (income), net | (1.8) | 1.9 |
| Income (loss) before income taxes and equity in net earnings of affiliates | 6.1 | (1.0) |
| &nbsp;&nbsp;&nbsp;Income tax provision (benefit) | (2.2) | 1.4 |
| Income (loss) before equity in net earnings of affiliates | 8.3 | (2.4) |
| &nbsp;&nbsp;&nbsp;Equity in net earnings of affiliates | 0.4 | 0.4 |
| Net income (loss) | 8.7 | (2.0) |
| Net loss attributable to noncontrolling interests | 0.1 |  |
| Net income (loss) attributable to AGCO Corporation | 8.8% | (1.9)% |

---

___________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;Rounding may impact summation of amounts.

&nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to AGCO Corporation for the three months ended September 30, 2025, was $305.7 million, or $4.09 per diluted share, compared to $30.0 million or $0.40 per diluted share, for the three months ended September 30, 2024. Net income (loss) attributable to AGCO Corporation for the nine months ended September 30, 2025, was $631.0 million, or $8.45 per diluted share, compared to $(169.1) million or $(2.27) per diluted share, for the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;Net sales during the three months ended September 30, 2025 were approximately $2,476.3 million, or 4.7% lower than the three months ended September 30, 2024, primarily due to lower sales volumes resulting from softer industry sales reflecting lower end market demand in the North America, South America and Asia/Pacific/Africa regions and the divestiture of the majority of the Company's G&P business on November 1, 2024, partially offset by higher sales volumes in the Europe/Middle East region and favorable currency impacts. Income from operations was $151.6 million for the three months ended September 30, 2025 compared to $114.8 million in the three months ended September 30, 2024. The increase in income from operations during 2025 was primarily the result of higher sales and production volumes in the Europe/Middle East region, decreases in restructuring and business optimization expenses and selling, general and administrative expenses ("SG&A expenses") primarily related to lower compensation and transaction costs, partially offset by higher amortization expense. Additionally, as of June 30, 2024, the Company classified its G&P business as held for sale and recorded a loss of $3.2 million during the three months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;Net sales during the nine months ended September 30, 2025 were approximately $7,161.8 million, or 18.4% lower than the nine months ended September 30, 2024, primarily due to lower sales volumes resulting from softer industry sales reflecting lower end market demand and the divestiture of the majority of the Company's G&P business on November 1, 2024, partially offset by favorable currency impacts. Income from operations was $365.0 million for the nine months ended

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

**(continued)**

September 30, 2025 compared to $146.7 million in the nine months ended September 30, 2024. As of June 30, 2024, the Company classified its G&P business as held for sale and recorded a loss of $497.8 million during the nine months ended September 30, 2024. Additionally, the increase in income from operations during 2025 was the result of decreases in engineering expenses and SG&A expenses primarily related to lower compensation and transaction costs, partially offset by lower sales and production volumes reflecting weak industry conditions.

&nbsp;&nbsp;&nbsp;&nbsp;We estimate that worldwide average price increases (decreases) were approximately 1.4% and (1.2)% for the three months ended September 30, 2025 and 2024, respectively, and 0.4% and (0.8)% for the nine months ended September 30, 2025 and 2024, respectively. Consolidated net sales of tractors and combines, which comprised approximately 68.6% and 67.0% of our net sales for the three and nine months ended September 30, 2025, increased (decreased) approximately 13.5% and (10.6)% compared to the same periods in 2024. Unit sales of tractors and combines increased (decreased) approximately 6.2% and (6.7)% during the three and nine months ended September 30, 2025 compared to the same periods in 2024. The primary driver of the change in unit sales was due to changes in end market demand. The difference between the unit sales change and the change in net sales was primarily the result of sales mix changes and foreign currency translation.

&nbsp;&nbsp;&nbsp;&nbsp;Overall, global production hours, excluding hours related to the Company's G&P business which was divested on November 1, 2024, increased (decreased) approximately 5.9% and (16.6)% during the three and nine months ended September 30, 2025, respectively, compared to the same periods in 2024, reflecting our response to end market demand and extended plant shutdowns in the Europe/Middle East region in the third quarter of 2024.

***Results of Operations***

&nbsp;&nbsp;&nbsp;&nbsp;Gross profit as a percentage of net sales increased during the three and nine months ended September 30, 2025 compared to the same periods in 2024, primarily due to lower manufacturing costs.

&nbsp;&nbsp;&nbsp;&nbsp;SG&A expenses, as a percentage of net sales, were higher during the three and nine months ended September 30, 2025 compared to the same periods in 2024 as net sales decreased at a faster rate than SG&A expenses. The absolute level of SG&A expenses decreased during the three and nine months ended September 30, 2025 due to lower compensation costs and lower transaction costs related to the divestiture of the majority of the Company's G&P business and the PTx Trimble joint venture transaction. We recorded $6.9 million and $24.3 million of stock compensation expense within SG&A expenses during the three and nine months ended September 30, 2025, respectively, compared to $5.0 million and $20.4 million during the same periods in 2024.

&nbsp;&nbsp;&nbsp;&nbsp;Engineering expenses, as a percentage of net sales, were higher during the three and nine months ended September 30, 2025 compared to the same periods in 2024 as net sales decreased at a faster rate than engineering expenses. The absolute value of engineering expenses were flat during the three months ended September 30, 2025. The absolute value of engineering expenses decreased during the nine months ended September 30, 2025 primarily due to lower investment, partially offset by increased engineering expenses related to the PTx Trimble joint venture.

&nbsp;&nbsp;&nbsp;&nbsp;We recorded impairment charges of $(0.6) million and $7.3 million during the three and nine months ended September 30, 2025, respectively, compared to $0.2 million and $5.3 million recorded during the three and nine months ended September 30, 2024, related to the impairment of certain other assets.

&nbsp;&nbsp;&nbsp;&nbsp;We recorded restructuring and business optimization expenses of $8.7 million and $37.3 million during the three and nine months ended September 30, 2025, respectively, compared to $10.5 million and $41.7 million during the same periods in 2024. On June 24, 2024, the Company announced a restructuring program (the "Program") in response to increased weakening demand in the agriculture industry. The Company estimates that it will incur charges for one-time termination benefits of approximately $150.0 million to $200.0 million in connection with the initial phase of the Program, primarily consisting of cash charges related to severance payments, employees benefits and related costs. The Company incurred the majority of charges in 2024 and expects to incur the remaining charges in 2025. The restructuring expenses recorded during the three and nine months ended September 30, 2025 and 2024 primarily related to severance, business optimization and other related costs associated with the Company's Program. Refer to Note 10 of our Condensed Consolidated Financial Statements for further information.

&nbsp;&nbsp;&nbsp;&nbsp;We recorded a loss on sale of business of $12.3 million during the nine months ended September 30, 2025 related to the finalization of the preliminary working capital and other adjustments related to the sale of the majority of the Company's G&P business. As of June 30, 2024, the Company classified its G&P business as held for sale and recorded a loss of

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

**(continued)**

$3.2 million and $497.8 million during the three and nine months ended September 30, 2024, respectively. Refer to Note 3 of our Condensed Consolidated Financial Statements for further information.

&nbsp;&nbsp;&nbsp;&nbsp;Interest expense, net was $15.5 million for the three months ended September 30, 2025, compared to $33.9 million for the comparable period in 2024, resulting primarily from a decrease in interest expense resulting from the Company's repayment of the Term Loan Facility on November 1, 2024. Interest expense, net was $51.8 million for the nine months ended September 30, 2025, compared to $65.7 million for the comparable period in 2024, resulting primarily from a decrease in interest expense resulting from the Company's repayment of the Term Loan Facility on November 1, 2024, partially offset by lower interest income. Refer to "Liquidity and Capital Resources" for further information on our available funding.

&nbsp;&nbsp;&nbsp;&nbsp;Other expense (income), net was $(208.4) million and $(127.2) million for the three and nine months ended September 30, 2025, respectively, compared to $52.3 million and $168.4 million for the comparable periods in 2024. During the three and nine months ended September 30, 2025, the Company recorded a gain of $251.9 million on the sale of an investment in affiliate related to the sale of the Company's ownership interest in Tractors and Farm Equipment Limited ("TAFE") within "Other expense (income), net." Refer to Note 20 of our Condensed Consolidated Financial Statements for further information. Foreign currency exchange losses were approximately $18.4 million and $60.6 million, respectively, for the three and nine months ended September 30, 2025, compared to $24.7 million and $74.3 million for the comparable periods in 2024. Losses on sales of receivables, primarily related to our accounts receivable sales agreements with our finance joint ventures in North America, Europe and Brazil and included in "Other expense (income), net," were approximately $21.9 million and $60.6 million, respectively, for the three and nine months ended September 30, 2025, compared to $28.4 million and $92.2 million for the comparable periods in 2024. During the nine months ended September 30, 2024, the Company recorded the final business interruption insurance recovery related to the 2022 cyber attack of $5.0 million.

&nbsp;&nbsp;&nbsp;&nbsp;We recorded an income tax provision (benefit) of $48.8 million and $(154.7) million for the three and nine months ended September 30, 2025, respectively, compared to $11.9 million and $122.6 million for the three and nine months ended September 30, 2024. Our effective tax rate varies from period to period due to the mix of taxable income and losses in the various tax jurisdictions in which we operate. During the three and nine months ended September 30, 2025, the Company's income tax provision included a net tax benefit of $4.7 million and $259.9 million, respectively, related to a legal entity reorganization. Based on a favorable tax ruling in Brazil regarding the taxability of certain state value added tax incentive benefits, the Company recorded a $31.7 million reduction in the provision for income taxes during the nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;Equity in net earnings of affiliates, which is primarily comprised of income from our AGCO Finance joint ventures, was $7.0 million and $30.7 million for the three months and nine ended September 30, 2025, respectively, compared to $12.2 million and $38.0 million for the three and nine months ended September 30, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;The Company recorded a net loss attributable to noncontrolling interests of $3.0 million and $5.2 million during the three and nine months ended September 30, 2025, respectively, compared to $1.1 million and $2.9 million recorded during the three and nine months ended September 30, 2024. The net loss primarily relates to the noncontrolling interests of the PTx Trimble joint venture held by Trimble, which owns a 15% interest in the joint venture.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

**(continued)**

***Results of Operations - Segment Information***

&nbsp;&nbsp;&nbsp;&nbsp;The Company has four operating segments which are also its reportable segments which consist of the Europe/Middle East ("EME"), North America, South America and Asia/Pacific/Africa ("APA") regions. The Company's reportable segments are geography based and distribute a full range of agricultural machinery and precision agriculture technology. The Company evaluates segment performance primarily based on income from operations. Sales for each segment are based on the location of the third-party customer. The Company's selling, general and administrative expenses and engineering expenses are charged to each segment based on the region and division where the expenses are incurred. As a result, the components of income (loss) from operations for one segment may not be comparable to another segment.

&nbsp;&nbsp;&nbsp;&nbsp;The following tables set forth, for the three and nine months ended September 30, 2025, the impact to net sales of currency translation by geographical segment (in millions, except percentages):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended September 30,** | **Three Months Ended September 30,** | **Change** | **Change Due to Currency Translation** |
| | **2025** | **2024** | $**%** | $**%** |
| Europe/Middle East | $1613.8 | $1266.0 | 27.5% | 7.2% |
| North America | 383.0 | 564.4 | (32.1)% | —% |
| South America | 322.4 | 350.8 | (8.1)% | 1.4% |
| Asia/Pacific/Africa | 157.1 | 166.9 | (5.9)% | (0.7)% |
| Total Segments | 2476.3 | 2348.1 | 5.5% | 4.1% |
| Other<sup>(1)</sup> |  | 251.2 | (100.0)% | —% |
|  | $2476.3 | $2599.3 | (4.7)% | 3.7% |

---

__________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;"Other" represents the results for the three months ended September 30, 2024 for the majority of the Company's Grain & Protein ("G&P") business which was divested on November 1, 2024. The results of the G&P business through the date of the divestiture were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

**(continued)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Nine Months Ended September 30,** | **Nine Months Ended September 30,** | **Change** | **Change Due to Currency Translation** |
| | **2025** | **2024** | $**%** | $**%** |
| Europe/Middle East | $4719.2 | $4842.4 | (2.5)% | 3.1% |
| North America | 1199.5 | 1792.7 | (33.1)% | (0.8)% |
| South America | 855.7 | 939.7 | (8.9)% | (4.9)% |
| Asia/Pacific/Africa | 387.4 | 458.0 | (15.4)% | (0.7)% |
| Total Segments | 7161.8 | 8032.8 | (10.8)% | 1.1% |
| Other<sup>(1)</sup> |  | 741.8 | (100.0)% | —% |
|  | $7161.8 | $8774.6 | (18.4)% | 1.0% |

---

__________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;"Other" represents the results for the nine months ended September 30, 2024 for the majority of the Company's G&P business which was divested on November 1, 2024. The results of the G&P business through the date of the divestiture were previously included within our North America, South America, Europe/Middle East and Asia/Pacific/Africa segments.

**EME**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended**<br>**September 30,** | **Three Months Ended**<br>**September 30,** | **Nine Months Ended**<br>**September 30,** | **Nine Months Ended**<br>**September 30,** | **Change** |
| | **2025** | **2024** | **2025** | **2024** | **$** |
| Net sales | $1613.8 | $1266.0 | $4719.2 | $4842.4 | $(123.2) |
| Income from operations | 252.4 | 89.3 | 668.1 | 680.0 | (11.9) |

---

&nbsp;&nbsp;&nbsp;&nbsp;Net sales in EME increased in the three months ended September 30, 2025 compared to the three months ended September 30, 2024, primarily due to sales volume increases, most significantly in high-horsepower tractors and mid-range tractors and favorable foreign currency translation. Income from operations increased by $163.1 million in the three months ended September 30, 2025 compared to the three months ended September 30, 2024 as a result of higher sales and production volumes.

&nbsp;&nbsp;&nbsp;&nbsp;Net sales in EME decreased in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024, primarily due to sales volume declines, most significantly in high-horsepower tractors and combines, partially offset by favorable foreign currency translation. Income from operations decreased by $11.9 million in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024 as a result of lower sales and production volumes and higher warranty costs.

**North America**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended**<br>**September 30,** | **Three Months Ended**<br>**September 30,** | **Nine Months Ended**<br>**September 30,** | **Nine Months Ended**<br>**September 30,** | **Change** |
| | **2025** | **2024** | **2025** | **2024** | **$** |
| Net sales | $383.0 | $564.4 | $1199.5 | $1792.7 | $(593.2) |
| Income (loss) from operations | (40.1) | 16.3 | (82.0) | 80.9 | (162.9) |

---

&nbsp;&nbsp;&nbsp;&nbsp;Net sales in North America decreased in the three months ended September 30, 2025 compared to the three months ended September 30, 2024, primarily due to sales volume declines, most significantly in high-horsepower tractors, sprayers and combines. Income (loss) from operations decreased by $56.4 million in the three months ended September 30, 2025 compared to the three months ended September 30, 2024 as a result of lower sales and production volumes.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

**(continued)**

&nbsp;&nbsp;&nbsp;&nbsp;Net sales in North America decreased in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024, primarily due to sales volume declines, most significantly in high-horsepower tractors, sprayers and hay tools. Income (loss) from operations decreased by $162.9 million in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024 as a result of lower sales and production volumes.

**South America**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended**<br>**September 30,** | **Three Months Ended**<br>**September 30,** | **Nine Months Ended**<br>**September 30,** | **Nine Months Ended**<br>**September 30,** | **Change** |
| | **2025** | **2024** | **2025** | **2024** | **$** |
| Net sales | $322.4 | $350.8 | $855.7 | $939.7 | $(84.0) |
| Income from operations | 18.5 | 41.1 | 44.4 | 59.5 | (15.1) |

---

&nbsp;&nbsp;&nbsp;&nbsp;Net sales decreased in South America in the three months ended September 30, 2025 compared to the three months ended September 30, 2024, primarily due to sales declines, most significantly in tractors and implements, and negative pricing impacts. Income from operations decreased $22.6 million in the three months ended September 30, 2025 compared to the three months ended September 30, 2024, as a result of lower sales and production volumes and negative pricing impacts.

&nbsp;&nbsp;&nbsp;&nbsp;Net sales decreased in South America in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024, primarily due to sales declines, most significantly in tractors and implements, negative pricing impacts and unfavorable foreign currency translation. Income from operations decreased $15.1 million in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024, as a result of lower sales and negative pricing impacts, partially offset by lower manufacturing costs.

**APA**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended**<br>**September 30,** | **Three Months Ended**<br>**September 30,** | **Nine Months Ended**<br>**September 30,** | **Nine Months Ended**<br>**September 30,** | **Change** |
| | **2025** | **2024** | **2025** | **2024** | **$** |
| Net sales | $157.1 | $166.9 | $387.4 | $458.0 | $(70.6) |
| Income from operations | 7.7 | 6.8 | 14.4 | 26.3 | (11.9) |

---

&nbsp;&nbsp;&nbsp;&nbsp;Net sales decreased in APA in the three months ended September 30, 2025 compared to the three months ended September 30, 2024, primarily due to sales volume declines, most significantly in hay tools. Income from operations increased $0.9 million in the three months ended September 30, 2025 compared to the three months ended September 30, 2024, primarily due to lower manufacturing costs, partially offset by lower sales volume.

&nbsp;&nbsp;&nbsp;&nbsp;Net sales decreased in APA in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024, primarily due to sales volume declines, most significantly in high-horsepower tractors, hay tools and sprayers. Income from operations decreased $11.9 million in the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024, primarily due to lower sales and production volumes.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

**(continued)**

**LIQUIDITY AND CAPITAL RESOURCES**

&nbsp;&nbsp;&nbsp;&nbsp;Our financing requirements generally are subject to variations due to seasonal changes in inventory and receivable levels. Internally generated funds are supplemented when necessary from external sources, primarily our credit facilities and accounts receivable sales agreement facilities. Additional information regarding our indebtedness is contained in Note 9 to the Condensed Consolidated Financial Statements. We believe that the borrowings and facilities listed below, together with available cash and internally generated funds, and assuming customary renewals and replacements, will be sufficient to support our working capital, capital expenditures and debt service requirements for the foreseeable future (in millions):

---

| | |
|:---|:---|
| | **September 30, 2025**<sup>(1)</sup> |
| Credit facility, expires 2027 | $350.0 |
| 5.450% Senior notes due 2027 | 400.0 |
| 5.800% Senior notes due 2034 | 700.0 |
| 0.800% Senior notes due 2028 | 704.0 |
| EIB Senior term loan due 2029 | 293.3 |
| EIB Senior term loan due 2030 | 199.5 |
| Senior term loans due between 2025 and 2028 | 98.0 |

---

____________________________________

<sup>(1)</sup> &nbsp;&nbsp;&nbsp;&nbsp;The amounts above are gross of debt issuance costs of an aggregate amount of approximately $10.4 million.

&nbsp;&nbsp;&nbsp;&nbsp;The Company has a credit facility providing for a $1.25 billion multi-currency unsecured revolving credit facility ("Credit Facility") that matures on December 19, 2027. In May 2025, the Company amended the Credit Facility with respect to the net leverage ratio financial covenant requirements for the remainder of 2025 and in the event of a future material acquisition. As of September 30, 2025, the Company had $350.0 million in outstanding borrowings under the revolving credit facility and had the ability to borrow $900.0 million.

&nbsp;&nbsp;&nbsp;&nbsp;In addition, the Company has an uncommitted revolving credit facility that allows the Company to borrow up to €200.0 million (or approximately $234.7 million as of September 30, 2025). The credit facility expires on December 31, 2026. As of September 30, 2025, the Company had no outstanding borrowings under the revolving credit facility.

&nbsp;&nbsp;&nbsp;&nbsp;The Company had redeemable noncontrolling interests of $301.3 million as of September 30, 2025 resulting from the PTx Trimble joint venture transaction, which may require the use of cash in certain instances, beginning in 2027. Refer to Note 2 of our Condensed Consolidated Financial Statements for further information.

&nbsp;&nbsp;&nbsp;&nbsp;The Company is in compliance with the financial covenants contained in these facilities and expects to continue to maintain such compliance. Should we ever encounter difficulties, our historical relationship with our lenders has been strong, and we anticipate their continued long-term support of our business.

&nbsp;&nbsp;&nbsp;&nbsp;Our debt to capitalization ratio, which is total indebtedness divided by the sum of total indebtedness, excluding short-term borrowings due within one year, and stockholders' equity, was 37.8% and 40.6% at September 30, 2025 and December 31, 2024, respectively.

***Supplemental Guarantor Financial Information***

&nbsp;&nbsp;&nbsp;&nbsp;On March 21, 2024, the Company issued (i) $400.0 million aggregate principal amount of 5.450% Senior Notes due 2027 (the "2027 Notes") and (ii) $700.0 million aggregate principal amount of 5.800% Senior Notes due 2034 (the "2034 Notes", and together with the 2027 Notes, the "Notes"). The 2027 Notes and the 2034 Notes are unsecured and unsubordinated indebtedness of the Company and are guaranteed on a senior unsecured basis, jointly and severally, by AGCO International Holdings B.V., AGCO International GmbH and Massey Ferguson Corp., direct and indirect subsidiaries of the Company (collectively, the "Guarantors").

&nbsp;&nbsp;&nbsp;&nbsp;The following tables present summarized financial information of AGCO Corporation, as the issuer of the 2027 Notes and the 2034 Notes, and the Guarantors on a combined basis after elimination of intercompany transactions and balances within the Guarantors and equity in the earnings from and investments in any non-guarantor subsidiary. As used herein, "obligor

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

**(continued)**

group" means AGCO Corporation, as the issuer of the debt securities, and the Guarantors on a combined basis. The summarized financial information is provided in accordance with the reporting requirements of Rule 13-01 under SEC Regulation S-X for the obligor group and is not intended to present the financial position or results of operations of the obligor group in accordance with generally accepted accounting principles as such principles are in effect in the United States.

*Balance Sheet Information*

---

| | | |
|:---|:---|:---|
| **(in millions)** | **As of September 30, 2025** | **As of December 31, 2024** |
| Current assets<sup>(a)</sup> | $4661.9 | $4143.4 |
| Noncurrent assets<sup>(b)</sup> | 1580.7 | 1910.6 |
| Current liabilities<sup>(c)</sup> | 3578.2 | 3802.8 |
| Noncurrent liabilities<sup>(d)</sup> | 4614.1 | 4214.5 |

---

____________________________________

<sup>(a)</sup>&nbsp;&nbsp;&nbsp;&nbsp;Includes amounts due from non-guarantor subsidiaries of $2,509.8 million and $2,189.6 million as of September 30, 2025 and December 31, 2024, respectively.

<sup>(b)</sup>&nbsp;&nbsp;&nbsp;&nbsp;Includes amounts due from non-guarantor subsidiaries of $107.3 million and $729.0 million as of September 30, 2025 and December 31, 2024, respectively.

<sup>(c)</sup>&nbsp;&nbsp;&nbsp;&nbsp;Includes amounts due to non-guarantor subsidiaries of $2,000.1 million and $1,972.8 million as of September 30, 2025 and December 31, 2024, respectively.

<sup>(d)</sup>&nbsp;&nbsp;&nbsp;&nbsp;Includes amounts due to non-guarantor subsidiaries of $1,557.2 million and $1,706.5 million as of September 30, 2025 and December 31, 2024, respectively.

*Statement of Operations Information*

---

| | |
|:---|:---|
| **(in millions)** | **Nine Months Ended September 30, 2025** |
| Revenues<sup>(a)</sup> | $5167.4 |
| Income from Operations | 260.3 |
| Net income | 191.2 |
| Net income attributable to obligor group | 191.2 |

---

____________________________________

<sup>(a)</sup>&nbsp;&nbsp;&nbsp;&nbsp;Includes intercompany revenues generated from non-guarantor subsidiaries of $3,554.3 million.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

**(continued)**

&nbsp;&nbsp;&nbsp;&nbsp;The following tables present summarized financial information of AGCO International GmbH, after elimination of intercompany transactions and balances within the Guarantors and equity in the earnings from and investments in any non-guarantor subsidiary.

*Balance Sheet Information*

---

| | | |
|:---|:---|:---|
| **(in millions)** | **As of September 30, 2025** | **As of December 31, 2024** |
| Current assets<sup>(a)</sup> | $3508.6 | $3136.1 |
| Noncurrent assets<sup>(b)</sup> | 379.6 | 991.0 |
| Current liabilities<sup>(c)</sup> | 2701.6 | 2650.4 |
| Noncurrent liabilities<sup>(d)</sup> | 1682.3 | 1815.9 |

---

____________________________________

<sup>(a)</sup>&nbsp;&nbsp;&nbsp;&nbsp;Includes amounts due from non-guarantor subsidiaries of $2,127.5 million and $1,895.5 million as of September 30, 2025 and December 31, 2024, respectively.

<sup>(b)</sup>&nbsp;&nbsp;&nbsp;&nbsp;Includes amounts due from non-guarantor subsidiaries of $102.7 million and $729.0 million as of September 30, 2025 and December 31, 2024, respectively.

<sup>(c)</sup>&nbsp;&nbsp;&nbsp;&nbsp;Includes amounts due to non-guarantor subsidiaries of $1,848.6 million and $1,863.9 million as of September 30, 2025 and December 31, 2024, respectively.

<sup>(d)</sup>&nbsp;&nbsp;&nbsp;&nbsp;Includes amounts due to non-guarantor subsidiaries of $1,557.2 million and $1,706.5 million as of September 30, 2025 and December 31, 2024, respectively.

*Statement of Operations Information*

---

| | |
|:---|:---|
| **(in millions)** | **Nine Months Ended September 30, 2025** |
| Revenues<sup>(a)</sup> | $4273.0 |
| Income from Operations | 538.2 |
| Net income | 205.0 |
| Net income attributable to obligor group | 205.0 |

---

____________________________________

<sup>(a)</sup>&nbsp;&nbsp;&nbsp;&nbsp;Includes intercompany revenues generated from non-guarantor subsidiaries of $3,336.9 million.

&nbsp;&nbsp;&nbsp;&nbsp;Our accounts receivable sales agreements in North America, Europe and Brazil permit the sale, on an ongoing basis, of a majority of our receivables to our U.S., Canadian, European and Brazilian finance joint ventures. The sales of all receivables are without recourse to us. We do not service the receivables after the sales occur, and we do not maintain any direct retained interest in the receivables. These agreements are accounted for as off-balance sheet transactions. The cash received from receivables sold under these accounts receivable sales agreements that remain outstanding as of September 30, 2025 and December 31, 2024 was approximately $2.0 billion and $2.3 billion, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;In addition, we sell certain trade receivables under factoring arrangements to other financial institutions around the world. The cash received from trade receivables sold under factoring arrangements that remain outstanding as of September 30, 2025 and December 31, 2024 was approximately $252.7 million and $220.5 million, respectively.

&nbsp;&nbsp;&nbsp;&nbsp;In order to efficiently manage our liquidity, we generally pay vendors in accordance with negotiated terms. To enable vendors to obtain payment in advance of our payment due dates to them, we have established programs in certain markets with financial institutions under which the vendors have the option to be paid by the financial institutions earlier than the payment due dates. Should we not be able to negotiate extended payment terms with our vendors, or should financial institutions no longer be willing to participate in early payment programs with us, we would expect to have sufficient liquidity to timely pay our vendors without any material impact on us or our financial position. As of September 30, 2025 and December 31, 2024, the amount outstanding that remains unpaid to the banks or other intermediaries associated with these programs totaled $34.3 million and $50.6 million, respectively. Refer to Note 8 of our Condensed Consolidated Financial Statements for further discussion.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

**(continued)**

**Cash Flows**

&nbsp;&nbsp;&nbsp;&nbsp;Cash flows provided by operating activities were approximately $224.5 million for the first nine months of 2025 compared to cash flows used in operating activities of approximately $108.0 million for the same period in 2024. Cash provided by operating activities during the nine months ended September 30, 2025 was driven by changes in working capital.

&nbsp;&nbsp;&nbsp;&nbsp;Our working capital requirements are seasonal, with investments in working capital typically building in the first half of the year and then reducing in the second half of the year. We had approximately $2,093.6 million in working capital at September 30, 2025 as compared to $1,312.0 million at December 31, 2024. Inventories as of September 30, 2025 were approximately $3,081.1 million as compared to $2,731.3 million at December 31, 2024. Accounts and notes receivable, net, as of September 30, 2025 were approximately $46.5 million lower than at December 31, 2024 primarily due to timing of sales of accounts receivable under our factoring arrangements. Accounts payable and Accrued expenses as of September 30, 2025 were approximately $114.3 million higher than at December 31, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;Capital expenditures for the first nine months of 2025 were approximately $159.3 million compared to $279.3 million for the same period in 2024.

**Share Repurchases and Dividends**

&nbsp;&nbsp;&nbsp;&nbsp;In November 2024, the Company entered into an accelerated share repurchase ("ASR") agreement with a financial institution to repurchase $22.0 million of shares of its common stock. The Company received approximately 228,969 shares associated with the completion of this transaction as of December 31, 2024. In November 2023, the Company entered into an ASR agreement with a financial institution to repurchase $53.0 million of shares of its common stock. The Company received approximately 371,669 shares associated with this transaction as of December 31, 2023. In January 2024, the Company received an additional 82,883 shares upon final settlement of its November 2023 ASR agreement. All shares received under the ASR agreement were retired upon receipt, and the excess of the purchase price over par value per share was recorded to a combination of "Additional paid-in capital" and "Retained earnings" within the Company's Condensed Consolidated Balance Sheets. On July 9, 2025, the Company's Board of Directors authorized a new share repurchase program authorizing the Company to repurchase up to $1.0 billion of the Company's common stock, which has no expiration date. As of September 30, 2025, the remaining amount authorized to be repurchased under board-approved share repurchase authorizations was approximately $1,035.0 million, which has no expiration date. We did not purchase any shares directly or enter into any accelerated share repurchase agreements during the three and nine months ended September 30, 2025. The Company plans to initiate $300 million in share repurchases in the fourth quarter of 2025, utilizing the $230 million of after-tax proceeds from the TAFE ownership sale, under the Company's share repurchase program. During the three months ended September 30, 2025 and 2024, the Company declared and paid cash dividends of $0.29 and $0.29 per common share, respectively. During the nine months ended September 30, 2025 and 2024, the Company declared and paid cash dividends of $0.87 and $3.37 per common share, respectively. The Company paid a special variable dividend of $2.50 per common share during the second quarter of 2024. On October 23, 2025, the Company's Board of Directors declared a regular quarterly dividend of $0.29 per common share to be paid on December 15, 2025, to all stockholders of record as of the close of business on November 14, 2025.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

**(continued)**

**COMMITMENTS, OFF-BALANCE SHEET ARRANGEMENTS AND CONTINGENCIES**

&nbsp;&nbsp;&nbsp;&nbsp;We are party to a number of commitments and other financial arrangements, which may include off-balance sheet arrangements. At September 30, 2025, we had outstanding guarantees issued to our Argentine finance joint venture, AGCO Capital, of approximately $70.3 million. In addition, we had accrued approximately $13.3 million of outstanding guarantees of residual values that may be owed to our finance joint ventures in the United States and Canada due upon expiration of certain eligible operating leases between the finance joint ventures and end users. The maximum potential amount of future payments under the guarantee is approximately $214.3 million.

&nbsp;&nbsp;&nbsp;&nbsp;We sell certain accounts receivable under factoring arrangements to our finance joint ventures and to financial institutions around the world. We account for the sale of such receivables as off balance sheet transactions. Our finance joint ventures in Europe, Brazil and Australia also provide wholesale financing directly to our dealers. As of September 30, 2025 and December 31, 2024, these finance joint ventures had approximately $87.1 million and $139.2 million, respectively, of outstanding accounts receivable associated with these arrangements. The total finance portfolio in our finance joint ventures was approximately $15.1 billion and $14.5 billion as of September 30, 2025 and December 31, 2024, respectively. The total finance portfolio as of September 30, 2025 and December 31, 2024 included approximately $12.7 billion and $11.3 billion, respectively, of retail receivables and $2.4 billion and $3.2 billion, respectively, of wholesale receivables from AGCO dealers.

**Contingencies**

&nbsp;&nbsp;&nbsp;&nbsp;We are party to various claims and lawsuits arising in the normal course of business. We closely monitor these claims and lawsuits and frequently consult with our legal counsel to determine whether they may, when resolved, have a material adverse effect on our financial position or results of operations and accrue and/or disclose loss contingencies as appropriate. Refer to Note 17 of our Condensed Consolidated Financial Statements for further information.

**OUTLOOK**

&nbsp;&nbsp;&nbsp;&nbsp;Global industry demand for farm equipment, driven by farm income, is expected to be moderately lower during 2025 in most major markets compared to 2024. Our net sales are expected to moderately decrease in 2025 compared to 2024, resulting from lower sales volumes partially offset by pricing, favorable currency translation and sales mix. Operating margins will reflect the impact of lower net sales, lower production volumes, partially offset by increased cost controls and flat engineering expenses.

&nbsp;&nbsp;&nbsp;&nbsp;Our outlook is based on current assumptions regarding a number of factors including demand, currency stability, pricing and market share gains. If our assumptions are incorrect, or other issues arise or return, such as tariffs or a worsening of our supply chain, our results of operations will be adversely impacted. Refer to "Risk Factors" in Item 1A of Part I of our Annual Report on Form 10-K for the year ended December 31, 2024 for further discussion.

**CRITICAL ACCOUNTING POLICIES AND ESTIMATES**

&nbsp;&nbsp;&nbsp;&nbsp;The discussion and analysis of our financial condition and results of operations are based upon our Condensed Consolidated Financial Statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. On an ongoing basis, management evaluates estimates, including those related to discount and sales incentive allowances, deferred income taxes and uncertain income tax positions, pensions, goodwill, other intangible and long-lived assets. Management bases these estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions. A description of critical accounting policies and related judgments and estimates that affect the preparation of our Condensed Consolidated Financial Statements is set forth in our Annual Report on Form 10-K for the year ended December 31, 2024.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

**(continued)**

**FORWARD-LOOKING STATEMENTS**

&nbsp;&nbsp;&nbsp;&nbsp;Certain statements in "Management's Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in this Quarterly Report on Form 10-Q are forward-looking, including certain statements set forth under the headings "Liquidity and Capital Resources" and "Outlook." Forward-looking statements reflect assumptions, expectations, projections, intentions or beliefs about future events. These statements, which may relate to such matters as earnings, net sales, margins, industry conditions, market demand, commodity prices, farm incomes, weather conditions, foreign currency translation impacts, general economic outlook, dividends, share repurchases, availability of financing, product development and enhancement, factory productivity, production and sales volumes, benefits from cost reduction initiatives, material costs, pricing impacts, tax rates, compliance with loan covenants, capital expenditures and working capital and debt service requirements are "forward-looking statements" within the meaning of the federal securities laws. These statements do not relate strictly to historical or current facts, and you can identify certain of these statements, but not necessarily all, by the use of the words "anticipate," "assumed," "indicate," "estimate," "believe," "predict," "forecast," "rely," "expect," "continue," "grow" and other words of similar meaning. Although we believe that the expectations and assumptions reflected in these statements are reasonable in view of the information currently available to us, there can be no assurance that these expectations will prove to be correct.

&nbsp;&nbsp;&nbsp;&nbsp;These forward-looking statements involve a number of risks and uncertainties, and actual results may differ materially from the results discussed in or implied by the forward-looking statements. Adverse changes in any of the following factors could cause actual results to differ materially from the forward-looking statements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;general economic and capital market conditions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;availability of credit to our retail customers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;the worldwide demand for agricultural products;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;grain stock levels and the levels of new and used field inventories;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;cost of steel and other raw materials;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;energy costs;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;performance and collectability of the accounts receivable originated or owned by AGCO or our finance joint ventures;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;government policies, tariffs and subsidies;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;uncertainty regarding changes in the international tariff regimes (including implementation of new tariffs and retaliatory measures) and product embargoes and their impact on the cost of the products that we sell;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;weather conditions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;interest and foreign currency exchange rates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;limitations on ability to repatriate funds;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;inflation, including in individual countries that have been designated as highly inflationary;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;pricing and product actions taken by competitors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;commodity prices, acreage planted and crop yields;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;farm income, land values, debt levels and access to credit;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;pervasive livestock diseases;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;production disruptions, including due to component and raw material availability;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;production levels and capacity constraints at our facilities, including those resulting from plant expansions and systems upgrades;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;integration of recent and future acquisitions, including the completed acquisition on April 1, 2024 of the Trimble ag assets and formation of the joint venture, PTx Trimble, and the ability to obtain the expected results;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;our expansion plans in emerging markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;supply constraints, including energy shortages;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;our cost reduction and control initiatives;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;our research and development efforts;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;dealer and distributor actions;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;regulations affecting privacy and data protection;

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**Management's Discussion and Analysis of Financial Condition and Results of Operations**

**(continued)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;technological difficulties;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;the impact of future pandemics on product demand and production;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;the occurrence of future cyberattacks, including ransomware attacks; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;•&nbsp;&nbsp;&nbsp;&nbsp;the conflict in Ukraine.

&nbsp;&nbsp;&nbsp;&nbsp;The recent announcements of significant trade policy and tariff actions by the U.S. government, including but not limited to tariffs on imported steel and aluminum products, tariffs on certain imports from China, tariffs on certain imports from Canada and Mexico, announced trade deal between the United States and European Union of baseline tariffs on certain imports from the European Union, and baseline tariffs on most imports from most other countries, continue to create significant uncertainty and potential risks for our business. These announcements in some cases were followed by delays and changes in implementation, and the ultimate tariff structures are unclear at the current time. Depending on the countries affected, increases in tariffs have raised the costs of inputs used in manufacturing our products, which in turn has impacted our cost of goods sold. Additionally, higher tariffs may lead to increased after-tariff sales prices for the products we sell. The impacts of the tariffs may be partially mitigated as a majority of our sales and manufacturing takes place outside the United States. While we are actively exploring opportunities to mitigate these increased costs, there can be no guarantee that we will be able to fully offset the impact of these tariffs. Furthermore, the imposition of retaliatory tariffs from other countries on our exported products could negatively affect our sales and marketplace access in those countries. Moreover, the uncertainty of the tariff changes and any future trade policy changes has adversely impacted, and is expected to continue to adversely impact, our sales.

&nbsp;&nbsp;&nbsp;&nbsp;We depend on suppliers for components, parts and raw materials for our products, and any failure by our suppliers to provide products as needed, or by us to promptly address supplier issues, will adversely impact our ability to timely and efficiently manufacture and sell products. In addition, the potential of future natural gas shortages in Europe, as well as predicted overall shortages in other energy sources, could also negatively impact our production and that of our supply chain in the future. There can be no assurance that there will not be future disruptions.

&nbsp;&nbsp;&nbsp;&nbsp;We have a substantial amount of indebtedness, and, as a result, we are subject to certain restrictive covenants and payment obligations that may adversely affect our ability to operate and expand our business.

&nbsp;&nbsp;&nbsp;&nbsp;Any forward-looking statement should be considered in light of such important factors. For additional factors and additional information regarding these factors, see "Risk Factors" in Item 1A of Part I of our Annual Report on Form 10-K for the year ended December 31, 2024.

&nbsp;&nbsp;&nbsp;&nbsp;New factors that could cause actual results to differ materially from those described above emerge from time to time, and it is not possible for us to predict all of such factors or the extent to which any such factor or combination of factors may cause actual results to differ from those contained in any forward-looking statement. Any forward-looking statement speaks only as of the date on which such statement is made, and we disclaim any obligation to update the information contained in such statement to reflect subsequent developments or information except as required by law.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**ITEM 3.&nbsp;&nbsp;&nbsp;&nbsp;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

**Foreign Currency Risk Management**

&nbsp;&nbsp;&nbsp;&nbsp;For quantitative and qualitative disclosures about market risks, see "Quantitative and Qualitative Disclosures About Market Risks" in Item 7A of Part II of our Annual Report on Form 10-K for the year ended December 31, 2024. As of the third quarter of 2025, there has been no material changes in our exposure to market risks.

**ITEM 4.&nbsp;&nbsp;&nbsp;&nbsp;CONTROLS AND PROCEDURES**

**Evaluation of Disclosure Controls and Procedures**

&nbsp;&nbsp;&nbsp;&nbsp;Our Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of September 30, 2025, have concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer's management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

&nbsp;&nbsp;&nbsp;&nbsp;The Company's management, including the Chief Executive Officer and the Chief Financial Officer, does not expect that the Company's disclosure controls or the Company's internal controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Because of the inherent limitations in a cost effective control system, misstatements due to error or fraud may occur and not be detected. We will conduct periodic evaluations of our internal controls to enhance, where necessary, our procedures and controls.

**Changes in Internal Control Over Financial Reporting**

&nbsp;&nbsp;&nbsp;&nbsp;There were no changes in our internal control over financial reporting identified in connection with the evaluation described above that occurred during the three months ended September 30, 2025 that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**PART II.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;OTHER INFORMATION**

**ITEM 1.&nbsp;&nbsp;&nbsp;&nbsp;LEGAL PROCEEDINGS**

&nbsp;&nbsp;&nbsp;&nbsp;We are a party to various other legal claims and actions incidental to our business. These items are more fully discussed in Note 17 to our Condensed Consolidated Financial Statements.

**ITEM 1A.&nbsp;&nbsp;&nbsp;&nbsp;RISK FACTORS**

&nbsp;&nbsp;&nbsp;&nbsp;There have been no material changes to our risks and uncertainties disclosed under "Risk Factors" in Item 1A of Part 1 of our Annual Report on Form 10-K for the year ended December 31, 2024. The risks and uncertainties described in our risk factors have the potential to materially affect our business, results of operations, financial condition and cash flows. These risks are not exclusive and additional risks to which we are subject include the factors mentioned under "Forward-Looking Statements" and the risks described in "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this Quarterly Report on Form 10-Q.

**ITEM 2.&nbsp;&nbsp;&nbsp;&nbsp;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS**

**Issuer Purchases of Equity Securities**

&nbsp;&nbsp;&nbsp;&nbsp;There were no purchases of our common stock made by or on behalf of us during the three months ended September 30, 2025.

**ITEM 5.&nbsp;&nbsp;&nbsp;&nbsp;OTHER INFORMATION**

&nbsp;&nbsp;&nbsp;&nbsp;During the three months ended September 30, 2025, none of our directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933).

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**ITEM 6.&nbsp;&nbsp;&nbsp;&nbsp;EXHIBITS**

*(Each management contract or compensation plan required to be filed as an exhibit is identified by an asterisk (\*). The Company is not filing, under Item 4, instruments defining the rights of holders of long-term debt where the debt does not exceed 10% of the Company's total assets. The Company agrees to furnish copies of those instruments to the Commission upon request.)*

---

| | | |
|:---|:---|:---|
| **Exhibit<br>Number** | **Description of Exhibit** | **The filings referenced for<br>incorporation by reference are<br>AGCO Corporation** |
| <u>[10.](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-1.htm)[1](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-1.htm)</u> | <u>[Amendment No. 3 to the Amended and Restated Letter Agreement, dated as of June 25, 2025, by and between AGCO Corporation and Tractors and Farm Equipment Limited](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-1.htm)</u> | July 1, 2025, Form 8-K, Exhibit 10.1 |
| <u>[10.](https://www.sec.gov/Archives/edgar/data/880266/000088026625000029/ex101-amendmentno4toarlett.htm)[2](https://www.sec.gov/Archives/edgar/data/880266/000088026625000029/ex101-amendmentno4toarlett.htm)</u> | <u>[Amendment No. 4 to the Amended and Restated Letter Agreement, dated as of July 7, 2025, by and between AGCO Corporation and Tractors and Farm Equipment Limited](https://www.sec.gov/Archives/edgar/data/880266/000088026625000029/ex101-amendmentno4toarlett.htm)</u> | July 8, 2025, Form 8-K, Exhibit 10.1 |
| <u>[10.](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-2.htm)[3](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-2.htm)</u> | <u>[Arbitrations Settlement Agreement, dated as of June 30, 2025, by and between AGCO Corporation, AGCO International GmbH, Tractors and Farm Equipment Limited and TAFE International Traktör ve Tarim Ekipmani Sanayi ve Ticaret Limited Sirketi](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-2.htm)</u> | July 1, 2025, Form 8-K, Exhibit 10.2 |
| <u>[10.](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-3.htm)[4](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-3.htm)</u> | <u>[India Litigation Settlement Agreement, dated as of June 30, 2025, by and amongst Tractors and Farm Equipment Limited, AGCO Corporation and the other parties thereto](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-3.htm)</u> | July 1, 2025, Form 8-K, Exhibit 10.3 |
| <u>[10.](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-4.htm)[5](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-4.htm)</u> | <u>[Intellectual Property Agreement, dated as of June 30, 2025, by and amongst Tractors and Farm Equipment Limited, Massey Ferguson Corp., AGCO Corporation, AGCO International GmbH, and AGCO Limited](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-4.htm)</u> | July 1, 2025, Form 8-K, Exhibit 10.4 |
| <u>[10.](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-5.htm)[6](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-5.htm)</u> | <u>[Buyback Agreement, dated as of June 30, 2025, by and amongst Tractors and Farm Equipment Limited and AGCO Holding B.V. and Trust Properties Development Company Private Limited](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-5.htm)</u> | July 1, 2025, Form 8-K, Exhibit 10.5 |
| <u>[10.](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-6.htm)[7](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-6.htm)</u> | <u>[Cooperation Agreement, dated as of June 30, 2025, by and among AGCO Corporation and Tractors and Farm Equipment Limited](https://www.sec.gov/Archives/edgar/data/880266/000110465925064417/tm2519453d1_ex10-6.htm)</u> | July 1, 2025, Form 8-K, Exhibit 10.6 |
| <u>[22.1](agcoex221-q32025.htm)</u> | <u>[List of Subsidiary Guarantors](agcoex221-q32025.htm)</u> | Filed herewith |
| <u>[31.1](agcoex311-q32025.htm)</u> | <u>[Certification of Eric P. Hansotia](agcoex311-q32025.htm)</u> | Filed herewith |
| <u>[31.2](agcoex312-q32025.htm)</u> | <u>[Certification of Damon Audia](agcoex312-q32025.htm)</u> | Filed herewith |
| <u>[32.1](agcoex321-q32025.htm)</u> | <u>[Certification of Eric P. Hansotia and Damon Audia](agcoex321-q32025.htm)</u> | Furnished herewith |
| 101 | The following unaudited financial information from this Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, are formatted in Inline XBRL: <br>(i) Condensed Consolidated Balance Sheets; <br>(ii) Condensed Consolidated Statements of Operations; <br>(iii) Condensed Consolidated Statements of Comprehensive Income (Loss); <br>(iv) Condensed Consolidated Statements of Cash Flows; and<br>(v) Notes to Condensed Consolidated Financial Statements | Filed herewith |
| 104 | Cover Page Interactive Data File - the cover page from this Quarterly Report on Form 10-Q for the quarter ended September 30, 2025 is formatted in Inline XBRL | Filed herewith |

---

------

<u>[**Table of Contents**](#icbbdaa10cdc945cb841aacb61b001220_7)</u>

**SIGNATURES**

&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | AGCO Corporation | AGCO Corporation |
| Date: | October 31, 2025 | By: | /s/ Damon Audia |
|  |  |  | Damon Audia<br>Senior Vice President and Chief Financial Officer<br>(Principal Financial Officer) |
|  |  |  | /s/ Indira Agarwal |
|  |  |  | Indira Agarwal<br>Vice President, Chief Accounting Officer<br>(Principal Accounting Officer) |

---

## Exhibit 22.1

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Exhibit 22.1**

**List of Subsidiary Guarantors**

&nbsp;&nbsp;&nbsp;&nbsp;As of September 30, 2025, the 5.450% Senior Notes due 2027 and the 5.800% Senior Notes due 2034 issued by AGCO Corporation are guaranteed by the following direct and indirect subsidiaries of AGCO Corporation:

---

| | |
|:---|:---|
| **Name of Subsidiary** | **State or Other Jurisdiction of Incorporation or Organization** |
| AGCO International Holdings B.V. | The Netherlands |
| AGCO International GmbH | Switzerland |
| Massey Ferguson Corp. | Delaware |

---

## Exhibit 31.1

**Exhibit 31.1**

**Certification Pursuant to § 302 of the Sarbanes-Oxley Act of 2002**

I, Eric P. Hansotia, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this Quarterly Report on Form 10-Q of AGCO Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Dated: | October 31, 2025 | |
| | | /s/ Eric P. Hansotia |
| | | Eric P. Hansotia |
| | | Chairman of the Board, President and Chief Executive Officer |

---

## Exhibit 31.2

**Exhibit 31.2**

**Certification Pursuant to § 302 of the Sarbanes-Oxley Act of 2002**

I, Damon Audia, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;I have reviewed this Quarterly Report on Form 10-Q of AGCO Corporation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Dated: | October 31, 2025 | |
| | | /s/ Damon Audia |
| | | Damon Audia |
| | | Senior Vice President and Chief Financial Officer |

---

## Exhibit 32.1

**Exhibit 32.1**

**CERTIFICATION**

&nbsp;&nbsp;&nbsp;&nbsp;The undersigned, as the Chairman of the Board, President and Chief Executive Officer and as the Senior Vice President and Chief Financial Officer of AGCO Corporation, respectively, certify that, to the best of their knowledge and belief, the Quarterly Report on Form 10-Q for the period ended September 30, 2025, which accompanies this certification fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and the information contained in the periodic report fairly presents, in all material respects, the financial condition and results of operations of AGCO Corporation at the dates and for the periods indicated. The foregoing certifications are made pursuant to 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. 1350) and shall not be relied upon for any other purpose.

---

| |
|:---|
| /s/ Eric P. Hansotia |
| Eric P. Hansotia |
| Chairman of the Board, President and Chief Executive Officer |
| October 31, 2025 |
| /s/ Damon Audia |
| Damon Audia |
| Senior Vice President and Chief Financial Officer |
| October 31, 2025 |

---

&nbsp;&nbsp;&nbsp;&nbsp;A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to AGCO Corporation and will be retained by AGCO Corporation and furnished to the Securities and Exchange Commission or its staff upon request.

<br>